PAK5
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O15013 | S1232 | Sugiyama | ARHGEF10 KIAA0294 | VKFIVLATALHEKDKDKsRDsLAPGPEPQDEDQKDALPSGG |
| O15357 | S1176 | Sugiyama | INPPL1 SHIP2 | RGLPsDyGRPLsFPPPRIREsIQEDLAEEAPCLQGGRASGL |
| O43159 | S309 | Sugiyama | RRP8 KIAA0409 NML hucep-1 | KKWPLQPVDRIARDLRQRPAsLVVADFGCGDCRLASSIRNP |
| O43847 | S94 | Sugiyama | NRDC NRD1 | ENSRVARLGADEsEEEGRRGsLsNAGDPEIVKsPsDPKQYR |
| O95831 | T281 | PSP | AIFM1 AIF PDCD8 | GGtPRsLsAIDRAGAEVKSRtTLFRKIGDFRsLEKISREVK |
| O96013 | S181 | Sugiyama | PAK4 KIAA1142 | KSSREGsGGPQESSRDKRPLsGPDVGtPQPAGLAsGAKLAA |
| O96013 | S41 | Sugiyama | PAK4 KIAA1142 | VHTGFDQHEQKFTGLPRQWQsLIEESARRPKPLVDPACITS |
| O96013 | T187 | Sugiyama | PAK4 KIAA1142 | sGGPQESSRDKRPLsGPDVGtPQPAGLAsGAKLAAGRPFNt |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S330 | Sugiyama | KRT8 CYK8 | MNRNISRLQAEIEGLKGQRAsLEAAIADAEQRGELAIKDAN |
| P06737 | S430 | Sugiyama | PYGL | KHLDRIVALFPKDVDRLRRMsLIEEEGSKRINMAHLCIVGS |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07737 | S58 | Sugiyama | PFN1 | KtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsL |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P15923 | S39 | PSP | TCF3 BHLHB21 E2A ITF1 | LLDFSMMFPLPVTNGKGRPAsLAGAQFGGsGLEDRPssGSW |
| P15976 | S161 | PSP | GATA1 ERYF1 GF1 | LSPDLLTLGPALPSSLPVPNsAYGGPDFSsTFFsPtGsPLN |
| P15976 | S187 | PSP | GATA1 ERYF1 GF1 | DFSsTFFsPtGsPLNSAAYSsPKLRGTLPLPPCEARECVNC |
| P16083 | S80 | Sugiyama | NQO2 NMOR2 | LSNPEVFNyGVEtHEAyKQRsLAsDITDEQKKVREADLVIF |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17844 | T69 | PSP | DDX5 G17P1 HELR HLR1 | DELPKFEKNFyQEHPDLARRtAQEVETYRRSKEITVRGHNC |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P23142 | T250 | Sugiyama | FBLN1 PP213 | GESCINTVGSFRCQRDssCGtGYELTEDNSCKDIDECESGI |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P25789 | T9 | Sugiyama | PSMA4 HC9 PSC9 | ____________MSRRyDsRttIFsPEGRLYQVEYAMEAIG |
| P26232 | T657 | Sugiyama | CTNNA2 CAPR | EDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P27448 | S42 | Sugiyama | MARK3 CTAK1 EMK2 | GDGRQEVTSRTSRSGARCRNsIAsCADEQPHIGNyRLLKTI |
| P27448 | S45 | Sugiyama | MARK3 CTAK1 EMK2 | RQEVTSRTSRSGARCRNsIAsCADEQPHIGNyRLLKTIGKG |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P30044 | S182 | Sugiyama | PRDX5 ACR1 SBBI10 | DLLLDDsLVsIFGNRRLKRFsMVVQDGIVKALNVEPDGTGL |
| P30048 | S199 | Sugiyama | PRDX3 AOP1 | SGLALRGLFIIDPNGVIKHLsVNDLPVGRSVEETLRLVKAF |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35221 | T658 | Sugiyama | CTNNA1 | LDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P43121 | S93 | Sugiyama | MCAM MUC18 | IFRVRQGQGQSEPGEYEQRLsLQDRGAtLALtQVtPQDERI |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P46013 | S648 | Sugiyama | MKI67 | RVSISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLG |
| P46940 | S482 | Sugiyama | IQGAP1 KIAA0051 | LINRALESGDVNTVWKQLsssVtGLTNIEEENCQRYLDELM |
| P46940 | T484 | Sugiyama | IQGAP1 KIAA0051 | NRALESGDVNTVWKQLsssVtGLTNIEEENCQRYLDELMKL |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P48643 | S51 | Sugiyama | CCT5 CCTE KIAA0098 | LEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtVT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P49736 | S229 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sHGHNVFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLP |
| P50395 | S427 | Sugiyama | GDI2 RABGDIB | ttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED__ |
| P51570 | S230 | Sugiyama | GALK1 GALK | LVPLSDPKLAVLITNSNVRHsLASSEYPVRRRQCEEVARAL |
| P51957 | S377 | Sugiyama | NEK4 STK2 | TELATISSVNIDILPAKGRDsVsDGFVQENQPRYLDASNEL |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62873 | S147 | Sugiyama | GNB1 | KTREGNVRVSRELAGHTGyLsCCRFLDDNQIVTSSGDTTCA |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| Q00610 | S146 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AVYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLL |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q05519 | S287 | PSP | SRSF11 SFRS11 | RRSRSRSRRRSHSKSRSRRRsKSPRRRRSHSRERGRRSRST |
| Q07866 | S524 | Sugiyama | KLC1 KLC KNS2 | QRVAEVLNDPENMEKRRsREsLNVDVVKYESGPDGGEEVSM |
| Q12789 | S1865 | Sugiyama | GTF3C1 | sPPEGQAPPsHsPRGTKRRAsWAsENGEtDAEGTQMtPAKR |
| Q13501 | S28 | Sugiyama | SQSTM1 ORCA OSIL | AYLLGKEDAAREIRRFsFCCsPEPEAEAEAAAGPGPCERLL |
| Q14566 | S271 | Sugiyama | MCM6 | VPDVSKLSTPGARAEtNsRVsGVDGyEtEGIRGLRALGVRD |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q5T1M5 | S1162 | Sugiyama | FKBP15 KIAA0674 | EAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRP |
| Q5TAX3 | S1383 | Sugiyama | TUT4 KIAA0191 ZCCHC11 | GDAGHVRRECPEVKLARQRNssVAAAQLVRNLVNAQQVAGS |
| Q6IBS0 | S139 | Sugiyama | TWF2 PTK9L MSTP011 | DELFGTVKDDLSFAGyQKHLssCAAPAPLtsAERELQQIRI |
| Q6IBS0 | S140 | Sugiyama | TWF2 PTK9L MSTP011 | ELFGTVKDDLSFAGyQKHLssCAAPAPLtsAERELQQIRIN |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q76FK4 | S296 | Sugiyama | NOL8 C9orf34 NOP132 | QKLKNLPFKTSGLETAKKRNsIsDDDtDsEDELRMMIAKEE |
| Q8N584 | S472 | Sugiyama | TTC39C C18orf17 | EVLYLWKALPNCSFPNLQRMsQACHEVDDSSVVGLKYLLLG |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8TCS8 | S767 | Sugiyama | PNPT1 PNPASE | LSRKVLQsPAtTVVRTLNDRssIVMGEPIsQSSSNsQ____ |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8TEW0 | S720 | Sugiyama | PARD3 PAR3 PAR3A | ELPIETALDDRERRIsHsLysGIEGLDEsPsRNAALsRIMG |
| Q8WXE0 | S403 | Sugiyama | CASKIN2 KIAA1139 | tysQLPRVGLsPDsPAGDRNsVGsEGsVGsIRSAGSGQSSE |
| Q969S3 | S38 | Sugiyama | ZNF622 ZPR9 | MQRAHYKTDWHRYNLRRKVAsMAPVTAEGFQERVRAQRAVA |
| Q96D15 | S117 | Sugiyama | RCN3 UNQ239/PRO272 | VsLAELRAWIAHTQQRHIRDsVsAAWDtyDtDRDGRVGWEE |
| Q96EP5 | S195 | Sugiyama | DAZAP1 | FHDIMGKKVEVKRAEPRDsKsQAPGQPGAsQWGsRVVPNAA |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q9BTC0 | S1026 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | VMVPKSILAKPsssPDPRYLsVPPsPNIstsEsRsPPEGDt |
| Q9C0C2 | S893 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LGtyssRDVsLGDWEFGKRDsLGAyAsQDANEQGQDLGKRD |
| Q9H0B6 | S428 | Sugiyama | KLC2 | NKPIWMHAEEREESKDKRRDsAPyGEyGsWYKACKVDsPtV |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9HA77 | T546 | Sugiyama | CARS2 OK/SW-cl.10 | CDTLRRGLTAHGINIKDRssttstWELLDQRTKDQKSAG__ |
| Q9HCN4 | S301 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | ANAESQQQREQLERLRKDMGsVALDAGtAKDsLsPVLHPsD |
| Q9NQU5 | S560 | Sugiyama | PAK6 PAK5 | VKLSDFGFCAQISKDVPKRKsLVGtPyWMAPEVISRSLYAT |
| Q9P286 | S573 | iPTMNet|PSP | PAK5 KIAA1264 PAK7 | LRALSYLHNQGVIHRDIKSDsILLTSDGRIKLSDFGFCAQV |
| Q9UBP0 | S92 | Sugiyama | SPAST ADPSP FSP2 KIAA1083 SPG4 | GLLFVWLCQRFSRALMAAKRssGAAPAPASASAPAPVPGGE |
| Q9UBU9 | S431 | Sugiyama | NXF1 TAP | HDGACCSLSIPFIPQNPARSsLAEyFKDSRNVKKLKDPTLR |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 3.772036e-10 | 9.423 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.089828e-08 | 7.963 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.284929e-08 | 7.138 | 1 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.007944e-07 | 6.997 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.641650e-07 | 6.785 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.534514e-07 | 6.814 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.070839e-07 | 6.684 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.320603e-07 | 6.634 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.446038e-07 | 6.612 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.002677e-07 | 6.222 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.800373e-06 | 5.745 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.462037e-06 | 5.609 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.526002e-06 | 5.598 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.307279e-06 | 5.481 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.258358e-06 | 5.487 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.179519e-06 | 5.498 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.448947e-06 | 5.352 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.394351e-06 | 5.268 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.613320e-06 | 5.251 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.138093e-06 | 5.289 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.997339e-06 | 5.301 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.673178e-06 | 5.246 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.718443e-06 | 5.060 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.405087e-06 | 5.027 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.254464e-05 | 4.902 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.545794e-05 | 4.811 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.681043e-05 | 4.774 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.006120e-05 | 4.698 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.498286e-05 | 4.602 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.924878e-05 | 4.534 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.973561e-05 | 4.527 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.881610e-05 | 4.540 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.160869e-05 | 4.500 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.389804e-05 | 4.470 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.514657e-05 | 4.454 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.977494e-05 | 4.400 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.350356e-05 | 4.361 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.350356e-05 | 4.361 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.768901e-05 | 4.322 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.843635e-05 | 4.315 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.123724e-05 | 4.290 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.300653e-05 | 4.276 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.290850e-05 | 4.201 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.342912e-05 | 4.198 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.480129e-05 | 4.188 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.692784e-05 | 4.174 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.698547e-05 | 4.114 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 9.795187e-05 | 4.009 | 1 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.233245e-04 | 3.909 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.248867e-04 | 3.903 | 1 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.262380e-04 | 3.899 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.717798e-04 | 3.765 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.933839e-04 | 3.714 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.086952e-04 | 3.680 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.184838e-04 | 3.661 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.473964e-04 | 3.607 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.957046e-04 | 3.529 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.066370e-04 | 3.513 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.015518e-04 | 3.521 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.305126e-04 | 3.481 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.226423e-04 | 3.491 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.195796e-04 | 3.495 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.544631e-04 | 3.450 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.011815e-04 | 3.397 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.087620e-04 | 3.389 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.139872e-04 | 3.383 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.326864e-04 | 3.364 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 4.433307e-04 | 3.353 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.462087e-04 | 3.350 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.562410e-04 | 3.341 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.657641e-04 | 3.332 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.123119e-04 | 3.290 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.186785e-04 | 3.285 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.260907e-04 | 3.279 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.433212e-04 | 3.265 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.552813e-04 | 3.255 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.598147e-04 | 3.252 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.706410e-04 | 3.244 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.706410e-04 | 3.244 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.713494e-04 | 3.243 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.752399e-04 | 3.171 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.752399e-04 | 3.171 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.232324e-04 | 3.141 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.621965e-04 | 3.064 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 9.394207e-04 | 3.027 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.623474e-04 | 3.017 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.934908e-04 | 3.003 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.934908e-04 | 3.003 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.001373e-03 | 2.999 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.097064e-03 | 2.960 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.071705e-03 | 2.970 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.062457e-03 | 2.974 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.111061e-03 | 2.954 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.195218e-03 | 2.923 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.286363e-03 | 2.891 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.258417e-03 | 2.900 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.256069e-03 | 2.901 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.287318e-03 | 2.890 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.427538e-03 | 2.845 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.442616e-03 | 2.841 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.567531e-03 | 2.805 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.580360e-03 | 2.801 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.597261e-03 | 2.797 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.964376e-03 | 2.707 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.471448e-03 | 2.607 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.552515e-03 | 2.593 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.703453e-03 | 2.568 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.873786e-03 | 2.542 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.810042e-03 | 2.551 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.745178e-03 | 2.561 | 1 | 1 |
| FLT3 Signaling | R-HSA-9607240 | 2.810042e-03 | 2.551 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.897307e-03 | 2.538 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.993773e-03 | 2.524 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.157537e-03 | 2.501 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.157537e-03 | 2.501 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.418665e-03 | 2.466 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.418665e-03 | 2.466 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.499543e-03 | 2.456 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.506732e-03 | 2.455 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.588278e-03 | 2.445 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.758278e-03 | 2.425 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.197977e-03 | 2.377 | 1 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.198453e-03 | 2.377 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.229999e-03 | 2.374 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.304309e-03 | 2.366 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.546901e-03 | 2.342 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.747382e-03 | 2.324 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.758859e-03 | 2.322 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.201269e-03 | 2.284 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.972473e-03 | 2.303 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.202501e-03 | 2.284 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.164436e-03 | 2.287 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.367812e-03 | 2.270 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.396349e-03 | 2.268 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.423435e-03 | 2.266 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.515702e-03 | 2.258 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.683368e-03 | 2.245 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.748919e-03 | 2.240 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.968211e-03 | 2.224 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.006336e-03 | 2.221 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 6.620528e-03 | 2.179 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 6.620528e-03 | 2.179 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 6.620528e-03 | 2.179 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.646029e-03 | 2.177 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.644070e-03 | 2.178 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.646029e-03 | 2.177 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.202969e-03 | 2.142 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.277703e-03 | 2.138 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.496307e-03 | 2.125 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.510671e-03 | 2.124 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.796922e-03 | 2.108 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.115255e-03 | 2.091 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.138618e-03 | 2.089 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.144553e-03 | 2.089 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.144553e-03 | 2.089 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 8.301333e-03 | 2.081 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.301333e-03 | 2.081 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.632432e-03 | 2.064 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.131778e-03 | 2.039 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.374086e-03 | 2.028 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.428750e-03 | 2.026 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.502776e-03 | 2.022 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.018609e-02 | 1.992 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.025240e-02 | 1.989 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.075157e-02 | 1.969 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.079172e-02 | 1.967 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.128701e-02 | 1.947 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.200154e-02 | 1.921 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.171445e-02 | 1.931 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.184100e-02 | 1.927 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.110846e-02 | 1.954 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.116794e-02 | 1.952 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.095096e-02 | 1.961 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.189585e-02 | 1.925 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.169955e-02 | 1.932 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.117282e-02 | 1.952 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.113311e-02 | 1.953 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.215017e-02 | 1.915 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.224379e-02 | 1.912 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.226074e-02 | 1.911 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.232341e-02 | 1.909 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.271757e-02 | 1.896 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.313952e-02 | 1.881 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.317299e-02 | 1.880 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.331639e-02 | 1.876 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.336165e-02 | 1.874 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.500980e-02 | 1.824 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.500980e-02 | 1.824 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.500980e-02 | 1.824 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.525060e-02 | 1.817 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.733279e-02 | 1.761 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.706610e-02 | 1.768 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.706610e-02 | 1.768 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.706610e-02 | 1.768 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.552530e-02 | 1.809 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.552530e-02 | 1.809 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.733149e-02 | 1.761 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.706610e-02 | 1.768 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.737246e-02 | 1.760 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.695568e-02 | 1.771 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.784756e-02 | 1.748 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.899590e-02 | 1.721 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.899590e-02 | 1.721 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.915631e-02 | 1.718 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.915631e-02 | 1.718 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.023751e-02 | 1.694 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.080633e-02 | 1.682 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.107121e-02 | 1.676 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.158692e-02 | 1.666 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.161608e-02 | 1.665 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.312448e-02 | 1.636 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.325936e-02 | 1.633 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.325936e-02 | 1.633 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.325936e-02 | 1.633 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.418064e-02 | 1.617 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.430033e-02 | 1.614 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.549208e-02 | 1.594 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.481547e-02 | 1.605 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.698985e-02 | 1.569 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.788522e-02 | 1.555 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.679066e-02 | 1.572 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.565547e-02 | 1.591 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.506007e-02 | 1.601 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.703096e-02 | 1.568 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.679815e-02 | 1.572 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.788522e-02 | 1.555 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.779447e-02 | 1.556 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.817122e-02 | 1.550 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.817122e-02 | 1.550 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.850661e-02 | 1.545 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.044398e-02 | 1.516 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.044398e-02 | 1.516 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.044732e-02 | 1.516 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.112138e-02 | 1.507 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.184403e-02 | 1.497 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.184614e-02 | 1.497 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.272594e-02 | 1.485 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.272594e-02 | 1.485 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.371782e-02 | 1.472 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.467167e-02 | 1.460 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.467167e-02 | 1.460 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.502108e-02 | 1.456 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.511744e-02 | 1.454 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.511744e-02 | 1.454 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.511744e-02 | 1.454 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.567141e-02 | 1.448 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.584782e-02 | 1.446 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.599230e-02 | 1.444 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 3.780511e-02 | 1.422 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.841740e-02 | 1.415 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.002070e-02 | 1.398 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.790967e-02 | 1.421 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.221281e-02 | 1.375 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.841740e-02 | 1.415 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.114734e-02 | 1.386 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.067264e-02 | 1.391 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.967576e-02 | 1.401 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.067264e-02 | 1.391 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.752325e-02 | 1.426 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.114734e-02 | 1.386 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.147025e-02 | 1.382 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.246173e-02 | 1.372 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.246173e-02 | 1.372 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.246173e-02 | 1.372 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.246173e-02 | 1.372 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.246173e-02 | 1.372 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.327624e-02 | 1.364 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.374463e-02 | 1.359 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.573194e-02 | 1.340 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.579539e-02 | 1.339 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.681804e-02 | 1.330 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.687142e-02 | 1.329 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.687142e-02 | 1.329 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.687142e-02 | 1.329 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.687142e-02 | 1.329 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.734695e-02 | 1.325 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.778064e-02 | 1.321 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.778064e-02 | 1.321 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.969949e-02 | 1.304 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.169991e-02 | 1.287 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.206906e-02 | 1.283 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.206906e-02 | 1.283 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.218660e-02 | 1.282 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.233224e-02 | 1.281 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.233224e-02 | 1.281 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 5.235002e-02 | 1.281 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 5.235002e-02 | 1.281 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 5.235002e-02 | 1.281 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 5.235002e-02 | 1.281 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.501715e-02 | 1.260 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.501715e-02 | 1.260 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.501715e-02 | 1.260 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.054622e-02 | 1.218 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.880871e-02 | 1.231 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.014305e-02 | 1.221 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.350704e-02 | 1.272 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.350704e-02 | 1.272 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.054622e-02 | 1.218 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.880871e-02 | 1.231 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.252931e-02 | 1.204 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.801970e-02 | 1.236 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.501715e-02 | 1.260 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 6.054622e-02 | 1.218 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.382492e-02 | 1.195 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.467910e-02 | 1.189 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.467910e-02 | 1.189 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.467910e-02 | 1.189 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.467910e-02 | 1.189 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.540653e-02 | 1.184 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.688854e-02 | 1.175 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.688854e-02 | 1.175 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.688854e-02 | 1.175 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.688854e-02 | 1.175 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.747824e-02 | 1.171 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.762462e-02 | 1.170 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.025150e-02 | 1.153 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.050460e-02 | 1.152 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.059640e-02 | 1.151 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.086656e-02 | 1.150 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 7.116707e-02 | 1.148 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.116707e-02 | 1.148 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.116707e-02 | 1.148 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.116707e-02 | 1.148 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.282562e-02 | 1.138 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.299686e-02 | 1.137 | 1 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.503187e-02 | 1.125 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.531014e-02 | 1.123 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 7.531014e-02 | 1.123 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.531014e-02 | 1.123 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 7.531014e-02 | 1.123 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.531014e-02 | 1.123 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.531824e-02 | 1.123 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.609816e-02 | 1.119 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.691366e-02 | 1.114 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.709524e-02 | 1.113 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.715120e-02 | 1.113 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.954624e-02 | 1.099 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.375797e-02 | 1.077 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.483631e-02 | 1.071 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.483631e-02 | 1.071 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 8.607968e-02 | 1.065 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 8.607968e-02 | 1.065 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.839380e-02 | 1.007 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.782667e-02 | 1.056 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.785390e-02 | 1.056 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.785390e-02 | 1.056 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.076017e-01 | 0.968 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.306714e-02 | 1.031 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.015246e-01 | 0.993 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.050013e-02 | 1.043 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 9.344792e-02 | 1.029 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.076017e-01 | 0.968 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.918842e-02 | 1.050 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.941752e-02 | 1.003 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.698799e-02 | 1.061 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.650674e-02 | 1.015 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.987061e-02 | 1.046 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.076017e-01 | 0.968 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.650674e-02 | 1.015 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.780116e-02 | 1.056 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 9.839380e-02 | 1.007 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.679067e-02 | 1.062 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.870213e-02 | 1.006 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.870213e-02 | 1.006 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.870213e-02 | 1.006 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.918842e-02 | 1.050 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.640215e-02 | 1.016 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.676472e-02 | 1.062 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.072828e-02 | 1.042 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.785390e-02 | 1.056 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.108126e-01 | 0.955 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.117713e-01 | 0.952 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.124867e-01 | 0.949 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.132045e-01 | 0.946 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.134194e-01 | 0.945 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.134194e-01 | 0.945 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.144940e-01 | 0.941 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.144940e-01 | 0.941 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.144940e-01 | 0.941 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.144940e-01 | 0.941 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.144940e-01 | 0.941 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.144940e-01 | 0.941 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.144940e-01 | 0.941 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.144940e-01 | 0.941 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.144940e-01 | 0.941 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.144940e-01 | 0.941 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.144940e-01 | 0.941 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.152631e-01 | 0.938 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.156285e-01 | 0.937 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.159446e-01 | 0.936 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.162628e-01 | 0.935 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.165555e-01 | 0.933 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.192658e-01 | 0.923 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.223497e-01 | 0.912 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.223497e-01 | 0.912 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.238974e-01 | 0.907 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.238974e-01 | 0.907 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.239307e-01 | 0.907 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.239307e-01 | 0.907 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.239307e-01 | 0.907 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.239307e-01 | 0.907 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 1.239307e-01 | 0.907 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.244468e-01 | 0.905 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.245097e-01 | 0.905 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.259349e-01 | 0.900 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.275292e-01 | 0.894 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.279896e-01 | 0.893 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.282797e-01 | 0.892 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.282797e-01 | 0.892 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.317972e-01 | 0.880 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.330824e-01 | 0.876 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.330824e-01 | 0.876 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.332654e-01 | 0.875 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.332654e-01 | 0.875 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.332654e-01 | 0.875 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.661227e-01 | 0.780 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.661227e-01 | 0.780 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.661227e-01 | 0.780 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.661227e-01 | 0.780 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.661227e-01 | 0.780 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.515590e-01 | 0.819 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.515590e-01 | 0.819 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.550853e-01 | 0.809 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.550853e-01 | 0.809 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.516644e-01 | 0.819 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 1.516644e-01 | 0.819 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.710547e-01 | 0.767 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.533373e-01 | 0.814 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.685889e-01 | 0.773 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.685889e-01 | 0.773 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.721267e-01 | 0.764 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.624432e-01 | 0.789 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.558947e-01 | 0.807 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.520383e-01 | 0.818 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.797663e-01 | 0.745 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.381479e-01 | 0.860 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.516644e-01 | 0.819 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.783335e-01 | 0.749 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.550853e-01 | 0.809 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.481413e-01 | 0.829 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.661227e-01 | 0.780 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.515590e-01 | 0.819 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 1.783335e-01 | 0.749 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.516644e-01 | 0.819 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.481413e-01 | 0.829 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.580281e-01 | 0.801 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 1.661227e-01 | 0.780 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.520383e-01 | 0.818 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.661227e-01 | 0.780 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 1.645343e-01 | 0.784 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.754467e-01 | 0.756 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 1.550853e-01 | 0.809 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.698605e-01 | 0.770 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.638965e-01 | 0.785 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.500963e-01 | 0.824 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.710547e-01 | 0.767 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.734293e-01 | 0.761 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.515590e-01 | 0.819 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.516644e-01 | 0.819 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.387603e-01 | 0.858 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.417838e-01 | 0.848 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.433908e-01 | 0.843 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.661227e-01 | 0.780 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.807019e-01 | 0.743 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.809104e-01 | 0.743 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.809104e-01 | 0.743 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.809104e-01 | 0.743 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.809104e-01 | 0.743 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.819269e-01 | 0.740 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.828274e-01 | 0.738 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.844746e-01 | 0.734 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.844746e-01 | 0.734 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.867665e-01 | 0.729 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.875090e-01 | 0.727 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.158850e-01 | 0.666 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.158850e-01 | 0.666 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.158850e-01 | 0.666 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.158850e-01 | 0.666 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.158850e-01 | 0.666 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.158850e-01 | 0.666 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.158850e-01 | 0.666 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.158850e-01 | 0.666 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.158850e-01 | 0.666 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.056719e-01 | 0.515 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.056719e-01 | 0.515 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.056719e-01 | 0.515 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.056719e-01 | 0.515 | 0 | 0 |
| Defective GALK1 causes GALCT2 | R-HSA-5609976 | 3.056719e-01 | 0.515 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.056719e-01 | 0.515 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.056719e-01 | 0.515 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.056719e-01 | 0.515 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.056719e-01 | 0.515 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.056719e-01 | 0.515 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.056719e-01 | 0.515 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.056719e-01 | 0.515 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.056719e-01 | 0.515 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.096869e-01 | 0.678 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.096869e-01 | 0.678 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.096869e-01 | 0.678 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.096869e-01 | 0.678 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.096869e-01 | 0.678 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.542107e-01 | 0.595 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.542107e-01 | 0.595 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.851823e-01 | 0.414 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.851823e-01 | 0.414 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.851823e-01 | 0.414 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.851823e-01 | 0.414 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.851823e-01 | 0.414 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.851823e-01 | 0.414 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.851823e-01 | 0.414 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.851823e-01 | 0.414 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.851823e-01 | 0.414 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.851823e-01 | 0.414 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.851823e-01 | 0.414 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.851823e-01 | 0.414 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.851823e-01 | 0.414 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.851823e-01 | 0.414 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.851823e-01 | 0.414 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.851823e-01 | 0.414 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.851823e-01 | 0.414 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.851823e-01 | 0.414 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.851823e-01 | 0.414 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.851823e-01 | 0.414 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.116224e-01 | 0.674 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.989038e-01 | 0.524 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.989038e-01 | 0.524 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 2.989038e-01 | 0.524 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.989038e-01 | 0.524 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.433476e-01 | 0.614 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.433476e-01 | 0.614 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.026576e-01 | 0.693 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.026576e-01 | 0.693 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.026576e-01 | 0.693 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.026576e-01 | 0.693 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.026576e-01 | 0.693 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.913422e-01 | 0.718 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 2.278847e-01 | 0.642 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.757607e-01 | 0.559 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.757607e-01 | 0.559 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.757607e-01 | 0.559 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.757607e-01 | 0.559 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.757607e-01 | 0.559 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.431440e-01 | 0.465 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 3.431440e-01 | 0.465 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 3.431440e-01 | 0.465 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.555916e-01 | 0.341 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.555916e-01 | 0.341 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.555916e-01 | 0.341 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.555916e-01 | 0.341 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.555916e-01 | 0.341 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.555916e-01 | 0.341 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.555916e-01 | 0.341 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.555916e-01 | 0.341 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.538425e-01 | 0.595 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.538425e-01 | 0.595 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.978993e-01 | 0.704 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.085619e-01 | 0.511 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.085619e-01 | 0.511 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.085619e-01 | 0.511 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.085619e-01 | 0.511 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.085619e-01 | 0.511 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.085619e-01 | 0.511 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.085619e-01 | 0.511 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.864493e-01 | 0.413 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.864493e-01 | 0.413 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.864493e-01 | 0.413 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.009500e-01 | 0.697 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.360223e-01 | 0.627 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.794253e-01 | 0.554 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.558719e-01 | 0.592 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.534309e-01 | 0.596 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.761506e-01 | 0.559 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.761506e-01 | 0.559 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.026558e-01 | 0.519 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.026558e-01 | 0.519 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.344378e-01 | 0.476 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.284540e-01 | 0.368 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.284540e-01 | 0.368 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.284540e-01 | 0.368 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.284540e-01 | 0.368 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 4.284540e-01 | 0.368 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.179413e-01 | 0.286 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.179413e-01 | 0.286 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.179413e-01 | 0.286 | 0 | 0 |
| MPS VI - Maroteaux-Lamy syndrome | R-HSA-2206285 | 5.179413e-01 | 0.286 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.179413e-01 | 0.286 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.717710e-01 | 0.566 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.967853e-01 | 0.528 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.616925e-01 | 0.442 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.616925e-01 | 0.442 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.616925e-01 | 0.442 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.616925e-01 | 0.442 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.205557e-01 | 0.656 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.067267e-01 | 0.391 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.067267e-01 | 0.391 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.067267e-01 | 0.391 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.688881e-01 | 0.329 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.688881e-01 | 0.329 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.688881e-01 | 0.329 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.862439e-01 | 0.543 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.736162e-01 | 0.428 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.189945e-01 | 0.496 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.189945e-01 | 0.496 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.099945e-01 | 0.509 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 4.159539e-01 | 0.381 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.159539e-01 | 0.381 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.265340e-01 | 0.486 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.432341e-01 | 0.464 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.375823e-01 | 0.472 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.869442e-01 | 0.412 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.427215e-01 | 0.354 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.075606e-01 | 0.295 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.075606e-01 | 0.295 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.075606e-01 | 0.295 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.075606e-01 | 0.295 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.769793e-01 | 0.424 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.350988e-01 | 0.475 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.484852e-01 | 0.605 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.677991e-01 | 0.330 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.012938e-01 | 0.397 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.443447e-01 | 0.264 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 5.443447e-01 | 0.264 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.443447e-01 | 0.264 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.298765e-01 | 0.276 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.839888e-01 | 0.315 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.203791e-01 | 0.284 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.203791e-01 | 0.284 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.076768e-01 | 0.294 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 4.454045e-01 | 0.351 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.793777e-01 | 0.319 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.583966e-01 | 0.253 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 5.211325e-01 | 0.283 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.477902e-01 | 0.261 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.266344e-01 | 0.278 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 4.665922e-01 | 0.331 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.911778e-01 | 0.719 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.093998e-01 | 0.509 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.717710e-01 | 0.566 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.009500e-01 | 0.697 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.076768e-01 | 0.294 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.445445e-01 | 0.352 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.904454e-01 | 0.537 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.019145e-01 | 0.695 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.498482e-01 | 0.456 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.786230e-01 | 0.320 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.133167e-01 | 0.290 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.076768e-01 | 0.294 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.449236e-01 | 0.352 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.538425e-01 | 0.595 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.009500e-01 | 0.697 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.913422e-01 | 0.718 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 5.583966e-01 | 0.253 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.907432e-01 | 0.309 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.354654e-01 | 0.271 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.564182e-01 | 0.591 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.116224e-01 | 0.674 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.757607e-01 | 0.559 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.072787e-01 | 0.512 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.688881e-01 | 0.329 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.167694e-01 | 0.664 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.109616e-01 | 0.386 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.133167e-01 | 0.290 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.260306e-01 | 0.371 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.132679e-01 | 0.384 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.699109e-01 | 0.328 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.909517e-01 | 0.408 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.909517e-01 | 0.408 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.542107e-01 | 0.595 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.542107e-01 | 0.595 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.116224e-01 | 0.674 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.116224e-01 | 0.674 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.431440e-01 | 0.465 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.177037e-01 | 0.498 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.091205e-01 | 0.680 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.688881e-01 | 0.329 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.427215e-01 | 0.354 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.131924e-01 | 0.504 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.907432e-01 | 0.309 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.871361e-01 | 0.312 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.477902e-01 | 0.261 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.648163e-01 | 0.333 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.828106e-01 | 0.417 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.384051e-01 | 0.269 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.085619e-01 | 0.511 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.026576e-01 | 0.693 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.159539e-01 | 0.381 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.500438e-01 | 0.602 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.716014e-01 | 0.430 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.757607e-01 | 0.559 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.864493e-01 | 0.413 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.284540e-01 | 0.368 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.082915e-01 | 0.681 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.067267e-01 | 0.391 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.699109e-01 | 0.328 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.618205e-01 | 0.336 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.762714e-01 | 0.322 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.384051e-01 | 0.269 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.536112e-01 | 0.257 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.762714e-01 | 0.322 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.571415e-01 | 0.254 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.427215e-01 | 0.354 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.075606e-01 | 0.295 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.443447e-01 | 0.264 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.406382e-01 | 0.267 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.809632e-01 | 0.318 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.031501e-01 | 0.395 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.411080e-01 | 0.618 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.116224e-01 | 0.674 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.116224e-01 | 0.674 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.124270e-01 | 0.673 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 3.085619e-01 | 0.511 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.360223e-01 | 0.627 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.558719e-01 | 0.592 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.265340e-01 | 0.486 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.814535e-01 | 0.419 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.411080e-01 | 0.618 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.298765e-01 | 0.276 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.476166e-01 | 0.606 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.391393e-01 | 0.470 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.496560e-01 | 0.456 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.261631e-01 | 0.487 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.278847e-01 | 0.642 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.989038e-01 | 0.524 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.431440e-01 | 0.465 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.538425e-01 | 0.595 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.009500e-01 | 0.697 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.026558e-01 | 0.519 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.284540e-01 | 0.368 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.388341e-01 | 0.470 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.889063e-01 | 0.410 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.688881e-01 | 0.329 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.699109e-01 | 0.328 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.075606e-01 | 0.295 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.583966e-01 | 0.253 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.337474e-01 | 0.273 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.571415e-01 | 0.254 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.118368e-01 | 0.291 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.538425e-01 | 0.595 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.601066e-01 | 0.444 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.640141e-01 | 0.249 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.026576e-01 | 0.693 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.699109e-01 | 0.328 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.386932e-01 | 0.269 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.558719e-01 | 0.592 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.728267e-01 | 0.428 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.907432e-01 | 0.309 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 4.067267e-01 | 0.391 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.249348e-01 | 0.280 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.848852e-01 | 0.415 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.227241e-01 | 0.491 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 2.116224e-01 | 0.674 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.085619e-01 | 0.511 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.085619e-01 | 0.511 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.085619e-01 | 0.511 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.864493e-01 | 0.413 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.009500e-01 | 0.697 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.742724e-01 | 0.427 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.616925e-01 | 0.442 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.067267e-01 | 0.391 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.039650e-01 | 0.690 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.534309e-01 | 0.596 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.479324e-01 | 0.459 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.869442e-01 | 0.412 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.612987e-01 | 0.583 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 3.616925e-01 | 0.442 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.691068e-01 | 0.329 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.203791e-01 | 0.284 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.076768e-01 | 0.294 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.281979e-01 | 0.277 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.723279e-01 | 0.565 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.057689e-01 | 0.687 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.989038e-01 | 0.524 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.538425e-01 | 0.595 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.904454e-01 | 0.537 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.427215e-01 | 0.354 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.137916e-01 | 0.503 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.076768e-01 | 0.294 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.076768e-01 | 0.294 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.451184e-01 | 0.264 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.032158e-01 | 0.692 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.431440e-01 | 0.465 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.284540e-01 | 0.368 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 4.386585e-01 | 0.358 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.354654e-01 | 0.271 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.136308e-01 | 0.383 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.016211e-01 | 0.695 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.465769e-01 | 0.262 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.467369e-01 | 0.460 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.210462e-01 | 0.376 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 5.341351e-01 | 0.272 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.077650e-01 | 0.294 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.648450e-01 | 0.333 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.158850e-01 | 0.666 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.158850e-01 | 0.666 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.056719e-01 | 0.515 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.851823e-01 | 0.414 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.851823e-01 | 0.414 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.851823e-01 | 0.414 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.913422e-01 | 0.718 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.278847e-01 | 0.642 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.555916e-01 | 0.341 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.555916e-01 | 0.341 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.085619e-01 | 0.511 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.803616e-01 | 0.552 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.864493e-01 | 0.413 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.565739e-01 | 0.591 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 3.414798e-01 | 0.467 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.414798e-01 | 0.467 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.072787e-01 | 0.512 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.179413e-01 | 0.286 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.179413e-01 | 0.286 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.179413e-01 | 0.286 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.179413e-01 | 0.286 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.179413e-01 | 0.286 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.179413e-01 | 0.286 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.904454e-01 | 0.537 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.688881e-01 | 0.329 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.189945e-01 | 0.496 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 4.386585e-01 | 0.358 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 4.386585e-01 | 0.358 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.814535e-01 | 0.419 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 4.427215e-01 | 0.354 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.075606e-01 | 0.295 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.909517e-01 | 0.408 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.443447e-01 | 0.264 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.443447e-01 | 0.264 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.443447e-01 | 0.264 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.443447e-01 | 0.264 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.976910e-01 | 0.303 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.451184e-01 | 0.264 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.583406e-01 | 0.253 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.940564e-01 | 0.712 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.019145e-01 | 0.695 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.133167e-01 | 0.290 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.676496e-01 | 0.435 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.736162e-01 | 0.428 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.176072e-01 | 0.286 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.125993e-01 | 0.384 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.978993e-01 | 0.704 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.176072e-01 | 0.286 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.072787e-01 | 0.512 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.375449e-01 | 0.624 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.065024e-01 | 0.391 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.067267e-01 | 0.391 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.076768e-01 | 0.294 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.677991e-01 | 0.330 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.734170e-01 | 0.325 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.116224e-01 | 0.674 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.026576e-01 | 0.693 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.978993e-01 | 0.704 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.864493e-01 | 0.413 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.786230e-01 | 0.320 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.995823e-01 | 0.523 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.137916e-01 | 0.503 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.261631e-01 | 0.487 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.461261e-01 | 0.609 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.427818e-01 | 0.265 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.542107e-01 | 0.595 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.989038e-01 | 0.524 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.414798e-01 | 0.467 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.179680e-01 | 0.662 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.160347e-01 | 0.665 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.284540e-01 | 0.368 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.284540e-01 | 0.368 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.179413e-01 | 0.286 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.067267e-01 | 0.391 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 4.691068e-01 | 0.329 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.015614e-01 | 0.696 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.354789e-01 | 0.628 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.716014e-01 | 0.430 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.286090e-01 | 0.483 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.203791e-01 | 0.284 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.824143e-01 | 0.417 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.583966e-01 | 0.253 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.443447e-01 | 0.264 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.003527e-01 | 0.301 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.166743e-01 | 0.664 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.056719e-01 | 0.515 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.851823e-01 | 0.414 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.116224e-01 | 0.674 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.555916e-01 | 0.341 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 3.864493e-01 | 0.413 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.864493e-01 | 0.413 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.414798e-01 | 0.467 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.019145e-01 | 0.695 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.072787e-01 | 0.512 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.794253e-01 | 0.554 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.284540e-01 | 0.368 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.284540e-01 | 0.368 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.889063e-01 | 0.410 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.386585e-01 | 0.358 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.075606e-01 | 0.295 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.839888e-01 | 0.315 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.575649e-01 | 0.340 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.026558e-01 | 0.519 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.009500e-01 | 0.697 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.743532e-01 | 0.562 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.978993e-01 | 0.704 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.118368e-01 | 0.291 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.742724e-01 | 0.427 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.762714e-01 | 0.322 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.601066e-01 | 0.444 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.555916e-01 | 0.341 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.344378e-01 | 0.476 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.717710e-01 | 0.566 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.159539e-01 | 0.381 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.075606e-01 | 0.295 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.298765e-01 | 0.276 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.948445e-01 | 0.306 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.325822e-01 | 0.274 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.899435e-01 | 0.409 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.298765e-01 | 0.276 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.067267e-01 | 0.391 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.019230e-01 | 0.396 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.431440e-01 | 0.465 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.431440e-01 | 0.465 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.479324e-01 | 0.459 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.159539e-01 | 0.381 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.674043e-01 | 0.435 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.065024e-01 | 0.391 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.571415e-01 | 0.254 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.046017e-01 | 0.393 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.116224e-01 | 0.674 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.075606e-01 | 0.295 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.466907e-01 | 0.460 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.072787e-01 | 0.512 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.521433e-01 | 0.345 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.414798e-01 | 0.467 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.354654e-01 | 0.271 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 5.217002e-01 | 0.283 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.962523e-01 | 0.402 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.124735e-01 | 0.385 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.688989e-01 | 0.245 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.571415e-01 | 0.254 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.298765e-01 | 0.276 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.691790e-01 | 0.245 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.691790e-01 | 0.245 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.691790e-01 | 0.245 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.691790e-01 | 0.245 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.731535e-01 | 0.242 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.731535e-01 | 0.242 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.731535e-01 | 0.242 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.731535e-01 | 0.242 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.731535e-01 | 0.242 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.731535e-01 | 0.242 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.731535e-01 | 0.242 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.731535e-01 | 0.242 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.731535e-01 | 0.242 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.731535e-01 | 0.242 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.731535e-01 | 0.242 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.731535e-01 | 0.242 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.731535e-01 | 0.242 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.791657e-01 | 0.237 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.791657e-01 | 0.237 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.791657e-01 | 0.237 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.791657e-01 | 0.237 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.791657e-01 | 0.237 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.791657e-01 | 0.237 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.791657e-01 | 0.237 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.791657e-01 | 0.237 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 5.791657e-01 | 0.237 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.791657e-01 | 0.237 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.819933e-01 | 0.235 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.858473e-01 | 0.232 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 5.858473e-01 | 0.232 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.858473e-01 | 0.232 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.863688e-01 | 0.232 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.874272e-01 | 0.231 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.925131e-01 | 0.227 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.925131e-01 | 0.227 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.925131e-01 | 0.227 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.925131e-01 | 0.227 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.925131e-01 | 0.227 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.925131e-01 | 0.227 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.925131e-01 | 0.227 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.936772e-01 | 0.226 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.989147e-01 | 0.223 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.989147e-01 | 0.223 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.050057e-01 | 0.218 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.090451e-01 | 0.215 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.107959e-01 | 0.214 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.119907e-01 | 0.213 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 6.119907e-01 | 0.213 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 6.119907e-01 | 0.213 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.119907e-01 | 0.213 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.119907e-01 | 0.213 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.119907e-01 | 0.213 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.119907e-01 | 0.213 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.119907e-01 | 0.213 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.119907e-01 | 0.213 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.121805e-01 | 0.213 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.121805e-01 | 0.213 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.145110e-01 | 0.211 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.150820e-01 | 0.211 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.150820e-01 | 0.211 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 6.150820e-01 | 0.211 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.150820e-01 | 0.211 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.163096e-01 | 0.210 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.181182e-01 | 0.209 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.189456e-01 | 0.208 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.215733e-01 | 0.207 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.220448e-01 | 0.206 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.220448e-01 | 0.206 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.220448e-01 | 0.206 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.220448e-01 | 0.206 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.220448e-01 | 0.206 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.220448e-01 | 0.206 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.220448e-01 | 0.206 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.220448e-01 | 0.206 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.220448e-01 | 0.206 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.220448e-01 | 0.206 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.220448e-01 | 0.206 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.220448e-01 | 0.206 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.220448e-01 | 0.206 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.220448e-01 | 0.206 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.220448e-01 | 0.206 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.220448e-01 | 0.206 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.220448e-01 | 0.206 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.231742e-01 | 0.205 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.294992e-01 | 0.201 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.360964e-01 | 0.196 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.368555e-01 | 0.196 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.368555e-01 | 0.196 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.368555e-01 | 0.196 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.368555e-01 | 0.196 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.368555e-01 | 0.196 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 6.368555e-01 | 0.196 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.373638e-01 | 0.196 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.373638e-01 | 0.196 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.373638e-01 | 0.196 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 6.428202e-01 | 0.192 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.428202e-01 | 0.192 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.428202e-01 | 0.192 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.428202e-01 | 0.192 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.428202e-01 | 0.192 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.428202e-01 | 0.192 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.428202e-01 | 0.192 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.428202e-01 | 0.192 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.438359e-01 | 0.191 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.470812e-01 | 0.189 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.571712e-01 | 0.182 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.578116e-01 | 0.182 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.578116e-01 | 0.182 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.597259e-01 | 0.181 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.613786e-01 | 0.180 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.613786e-01 | 0.180 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.613786e-01 | 0.180 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.613786e-01 | 0.180 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.613786e-01 | 0.180 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.642184e-01 | 0.178 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.653387e-01 | 0.177 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.653387e-01 | 0.177 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.653387e-01 | 0.177 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.653387e-01 | 0.177 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.653387e-01 | 0.177 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.653387e-01 | 0.177 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.653387e-01 | 0.177 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.653387e-01 | 0.177 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.708425e-01 | 0.173 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.716805e-01 | 0.173 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.716805e-01 | 0.173 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.716805e-01 | 0.173 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.716805e-01 | 0.173 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.716805e-01 | 0.173 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.716805e-01 | 0.173 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.716805e-01 | 0.173 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.727997e-01 | 0.172 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.746826e-01 | 0.171 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.746826e-01 | 0.171 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.787830e-01 | 0.168 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.842186e-01 | 0.165 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.842186e-01 | 0.165 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.842186e-01 | 0.165 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.842186e-01 | 0.165 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.928394e-01 | 0.159 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.928394e-01 | 0.159 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.942451e-01 | 0.158 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.986183e-01 | 0.156 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.986183e-01 | 0.156 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.986183e-01 | 0.156 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.986183e-01 | 0.156 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.986183e-01 | 0.156 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.986183e-01 | 0.156 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.986183e-01 | 0.156 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 6.986183e-01 | 0.156 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.986183e-01 | 0.156 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.986183e-01 | 0.156 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.986183e-01 | 0.156 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.986183e-01 | 0.156 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.036755e-01 | 0.153 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.036755e-01 | 0.153 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.036755e-01 | 0.153 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.036755e-01 | 0.153 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 7.036755e-01 | 0.153 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.036755e-01 | 0.153 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.036755e-01 | 0.153 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.036755e-01 | 0.153 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.036755e-01 | 0.153 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.036755e-01 | 0.153 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.036755e-01 | 0.153 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.036755e-01 | 0.153 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.036755e-01 | 0.153 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.036755e-01 | 0.153 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 7.036755e-01 | 0.153 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.036755e-01 | 0.153 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.036755e-01 | 0.153 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.036755e-01 | 0.153 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.041515e-01 | 0.152 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.058874e-01 | 0.151 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.058874e-01 | 0.151 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.058874e-01 | 0.151 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.058874e-01 | 0.151 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.063935e-01 | 0.151 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.096900e-01 | 0.149 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.115361e-01 | 0.148 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.156591e-01 | 0.145 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.156591e-01 | 0.145 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.156591e-01 | 0.145 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.193515e-01 | 0.143 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.236951e-01 | 0.140 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 7.236951e-01 | 0.140 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.236951e-01 | 0.140 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 7.236951e-01 | 0.140 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.236951e-01 | 0.140 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.236951e-01 | 0.140 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.263977e-01 | 0.139 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.263977e-01 | 0.139 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.269151e-01 | 0.139 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.286096e-01 | 0.138 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.286153e-01 | 0.138 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.324584e-01 | 0.135 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.359361e-01 | 0.133 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.373914e-01 | 0.132 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.376227e-01 | 0.132 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.376227e-01 | 0.132 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.376227e-01 | 0.132 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.376227e-01 | 0.132 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.376227e-01 | 0.132 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.376227e-01 | 0.132 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.376227e-01 | 0.132 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.376227e-01 | 0.132 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.376227e-01 | 0.132 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.376227e-01 | 0.132 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.376227e-01 | 0.132 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.376227e-01 | 0.132 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.376227e-01 | 0.132 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.376227e-01 | 0.132 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.376227e-01 | 0.132 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.402792e-01 | 0.131 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.408666e-01 | 0.130 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.410073e-01 | 0.130 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.414091e-01 | 0.130 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.430451e-01 | 0.129 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.457697e-01 | 0.127 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.457697e-01 | 0.127 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.469839e-01 | 0.127 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.469839e-01 | 0.127 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.469839e-01 | 0.127 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.469839e-01 | 0.127 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.469839e-01 | 0.127 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.498895e-01 | 0.125 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.500268e-01 | 0.125 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.500268e-01 | 0.125 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.500268e-01 | 0.125 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.500672e-01 | 0.125 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.562815e-01 | 0.121 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.632998e-01 | 0.117 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.640295e-01 | 0.117 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.640295e-01 | 0.117 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.640295e-01 | 0.117 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.659730e-01 | 0.116 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.659730e-01 | 0.116 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.659730e-01 | 0.116 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.665422e-01 | 0.115 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.676826e-01 | 0.115 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.676826e-01 | 0.115 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.676826e-01 | 0.115 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.676826e-01 | 0.115 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.676826e-01 | 0.115 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.676826e-01 | 0.115 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.676826e-01 | 0.115 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.676826e-01 | 0.115 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.676826e-01 | 0.115 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.676826e-01 | 0.115 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.676826e-01 | 0.115 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.676826e-01 | 0.115 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 7.676826e-01 | 0.115 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.676826e-01 | 0.115 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.676826e-01 | 0.115 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.676826e-01 | 0.115 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.685650e-01 | 0.114 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.685650e-01 | 0.114 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.685650e-01 | 0.114 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.685650e-01 | 0.114 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 7.685650e-01 | 0.114 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.701878e-01 | 0.113 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.705031e-01 | 0.113 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.705031e-01 | 0.113 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.705031e-01 | 0.113 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.705566e-01 | 0.113 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.719212e-01 | 0.112 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.763296e-01 | 0.110 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.812082e-01 | 0.107 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.812082e-01 | 0.107 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.812082e-01 | 0.107 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.840827e-01 | 0.106 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.885240e-01 | 0.103 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.885240e-01 | 0.103 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.885240e-01 | 0.103 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.885240e-01 | 0.103 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.943002e-01 | 0.100 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.943002e-01 | 0.100 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.943002e-01 | 0.100 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.943002e-01 | 0.100 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 7.943002e-01 | 0.100 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 7.943002e-01 | 0.100 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.943002e-01 | 0.100 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.943002e-01 | 0.100 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 7.943002e-01 | 0.100 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.943002e-01 | 0.100 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.943002e-01 | 0.100 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.943002e-01 | 0.100 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.943002e-01 | 0.100 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.943002e-01 | 0.100 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 7.943002e-01 | 0.100 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.943002e-01 | 0.100 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.943002e-01 | 0.100 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 7.943002e-01 | 0.100 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.943002e-01 | 0.100 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.943002e-01 | 0.100 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.970309e-01 | 0.099 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.970309e-01 | 0.099 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.970309e-01 | 0.099 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.985543e-01 | 0.098 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.987270e-01 | 0.098 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.045183e-01 | 0.094 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.062371e-01 | 0.094 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.069493e-01 | 0.093 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.069493e-01 | 0.093 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.090477e-01 | 0.092 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.093604e-01 | 0.092 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.124657e-01 | 0.090 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.124657e-01 | 0.090 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.178695e-01 | 0.087 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.178695e-01 | 0.087 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.178695e-01 | 0.087 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.178695e-01 | 0.087 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.178695e-01 | 0.087 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.178695e-01 | 0.087 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.178695e-01 | 0.087 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.178695e-01 | 0.087 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.178695e-01 | 0.087 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.178695e-01 | 0.087 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.178695e-01 | 0.087 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.178695e-01 | 0.087 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.178695e-01 | 0.087 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.178695e-01 | 0.087 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.197799e-01 | 0.086 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.210855e-01 | 0.086 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.213511e-01 | 0.085 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.218854e-01 | 0.085 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.218854e-01 | 0.085 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.224020e-01 | 0.085 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.224020e-01 | 0.085 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.224020e-01 | 0.085 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.239301e-01 | 0.084 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.239301e-01 | 0.084 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.239301e-01 | 0.084 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.239301e-01 | 0.084 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.239301e-01 | 0.084 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.239301e-01 | 0.084 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.239301e-01 | 0.084 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.239301e-01 | 0.084 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.239301e-01 | 0.084 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.239301e-01 | 0.084 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.266230e-01 | 0.083 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.266230e-01 | 0.083 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.320414e-01 | 0.080 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 8.326930e-01 | 0.080 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.340014e-01 | 0.079 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.344892e-01 | 0.079 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.387394e-01 | 0.076 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.387394e-01 | 0.076 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.387394e-01 | 0.076 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.387394e-01 | 0.076 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.387394e-01 | 0.076 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.387394e-01 | 0.076 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.387394e-01 | 0.076 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.387394e-01 | 0.076 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.387394e-01 | 0.076 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.395556e-01 | 0.076 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.395556e-01 | 0.076 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.395556e-01 | 0.076 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.398547e-01 | 0.076 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.424664e-01 | 0.074 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.424997e-01 | 0.074 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.427857e-01 | 0.074 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.436296e-01 | 0.074 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.436296e-01 | 0.074 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.454210e-01 | 0.073 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.454210e-01 | 0.073 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.482274e-01 | 0.071 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.498497e-01 | 0.071 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.507406e-01 | 0.070 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.508926e-01 | 0.070 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.511710e-01 | 0.070 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.511710e-01 | 0.070 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.511710e-01 | 0.070 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.518349e-01 | 0.070 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.522036e-01 | 0.069 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.527952e-01 | 0.069 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.527952e-01 | 0.069 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.539133e-01 | 0.069 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.539133e-01 | 0.069 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.539133e-01 | 0.069 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.561705e-01 | 0.067 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.572190e-01 | 0.067 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 8.572190e-01 | 0.067 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.572190e-01 | 0.067 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.572190e-01 | 0.067 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.572190e-01 | 0.067 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.572190e-01 | 0.067 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.572190e-01 | 0.067 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.572190e-01 | 0.067 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.572190e-01 | 0.067 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.572190e-01 | 0.067 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.572190e-01 | 0.067 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.572190e-01 | 0.067 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.572190e-01 | 0.067 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.579020e-01 | 0.067 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.583551e-01 | 0.066 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.607121e-01 | 0.065 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.612181e-01 | 0.065 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.616756e-01 | 0.065 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.616756e-01 | 0.065 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.622685e-01 | 0.064 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.622685e-01 | 0.064 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.637129e-01 | 0.064 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.657190e-01 | 0.063 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.670886e-01 | 0.062 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.670886e-01 | 0.062 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.678341e-01 | 0.062 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.686375e-01 | 0.061 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.702961e-01 | 0.060 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.704093e-01 | 0.060 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.712471e-01 | 0.060 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.721343e-01 | 0.059 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.735818e-01 | 0.059 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.735818e-01 | 0.059 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.735818e-01 | 0.059 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.735818e-01 | 0.059 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.735818e-01 | 0.059 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.735818e-01 | 0.059 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.735818e-01 | 0.059 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.735818e-01 | 0.059 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.735818e-01 | 0.059 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.744260e-01 | 0.058 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.744260e-01 | 0.058 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 8.744260e-01 | 0.058 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.744260e-01 | 0.058 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.757666e-01 | 0.058 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.757666e-01 | 0.058 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.757666e-01 | 0.058 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.757666e-01 | 0.058 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.762050e-01 | 0.057 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.762050e-01 | 0.057 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.771920e-01 | 0.057 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.791637e-01 | 0.056 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.791637e-01 | 0.056 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.791637e-01 | 0.056 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.791637e-01 | 0.056 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.831649e-01 | 0.054 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.843857e-01 | 0.053 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.843857e-01 | 0.053 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.846680e-01 | 0.053 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.855396e-01 | 0.053 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.880703e-01 | 0.052 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.880703e-01 | 0.052 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.880703e-01 | 0.052 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.880703e-01 | 0.052 | 0 | 0 |
| The activation of arylsulfatases | R-HSA-1663150 | 8.880703e-01 | 0.052 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.880703e-01 | 0.052 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.880703e-01 | 0.052 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.880703e-01 | 0.052 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.880703e-01 | 0.052 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.894258e-01 | 0.051 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.902178e-01 | 0.051 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.902178e-01 | 0.051 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.902178e-01 | 0.051 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.902178e-01 | 0.051 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.902178e-01 | 0.051 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.902178e-01 | 0.051 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.902553e-01 | 0.050 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.906476e-01 | 0.050 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.918130e-01 | 0.050 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.936341e-01 | 0.049 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.951812e-01 | 0.048 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.967618e-01 | 0.047 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.987262e-01 | 0.046 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.003263e-01 | 0.046 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.003263e-01 | 0.046 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.003263e-01 | 0.046 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.008141e-01 | 0.045 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.008991e-01 | 0.045 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.008991e-01 | 0.045 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.008991e-01 | 0.045 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.008991e-01 | 0.045 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.008991e-01 | 0.045 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.008991e-01 | 0.045 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 9.008991e-01 | 0.045 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.008991e-01 | 0.045 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.008991e-01 | 0.045 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.008991e-01 | 0.045 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.008991e-01 | 0.045 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.022617e-01 | 0.045 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.050837e-01 | 0.043 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.068934e-01 | 0.042 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.073525e-01 | 0.042 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.089221e-01 | 0.041 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.095606e-01 | 0.041 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.095606e-01 | 0.041 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.095606e-01 | 0.041 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.095606e-01 | 0.041 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.095606e-01 | 0.041 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.101608e-01 | 0.041 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.101608e-01 | 0.041 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.101608e-01 | 0.041 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.118379e-01 | 0.040 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.120215e-01 | 0.040 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.120994e-01 | 0.040 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.122582e-01 | 0.040 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.122582e-01 | 0.040 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.122582e-01 | 0.040 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.122582e-01 | 0.040 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 9.122582e-01 | 0.040 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.122582e-01 | 0.040 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.122582e-01 | 0.040 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.122582e-01 | 0.040 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.122582e-01 | 0.040 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.122582e-01 | 0.040 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.122582e-01 | 0.040 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.143497e-01 | 0.039 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.151815e-01 | 0.038 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.175179e-01 | 0.037 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.175179e-01 | 0.037 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.179883e-01 | 0.037 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.179883e-01 | 0.037 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.197721e-01 | 0.036 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.209816e-01 | 0.036 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.210590e-01 | 0.036 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.210590e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.212924e-01 | 0.036 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.223158e-01 | 0.035 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.223158e-01 | 0.035 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.223158e-01 | 0.035 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.223158e-01 | 0.035 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.223158e-01 | 0.035 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.223158e-01 | 0.035 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 9.223158e-01 | 0.035 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 9.223158e-01 | 0.035 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.223158e-01 | 0.035 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.223158e-01 | 0.035 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.223158e-01 | 0.035 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.223158e-01 | 0.035 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.223796e-01 | 0.035 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.225346e-01 | 0.035 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.243213e-01 | 0.034 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.243213e-01 | 0.034 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.256729e-01 | 0.034 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.256729e-01 | 0.034 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.256729e-01 | 0.034 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.256729e-01 | 0.034 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.256729e-01 | 0.034 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.256729e-01 | 0.034 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.265730e-01 | 0.033 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.272890e-01 | 0.033 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.290903e-01 | 0.032 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.290903e-01 | 0.032 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.292905e-01 | 0.032 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.306065e-01 | 0.031 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.306065e-01 | 0.031 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.312211e-01 | 0.031 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 9.312211e-01 | 0.031 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.312211e-01 | 0.031 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.312211e-01 | 0.031 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.312211e-01 | 0.031 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 9.312211e-01 | 0.031 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.312211e-01 | 0.031 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.312211e-01 | 0.031 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.312211e-01 | 0.031 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.312211e-01 | 0.031 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.312211e-01 | 0.031 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.312211e-01 | 0.031 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.312211e-01 | 0.031 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.326740e-01 | 0.030 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.326740e-01 | 0.030 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.327496e-01 | 0.030 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.364081e-01 | 0.029 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.364081e-01 | 0.029 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.364081e-01 | 0.029 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.364081e-01 | 0.029 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.390473e-01 | 0.027 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.390473e-01 | 0.027 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.390473e-01 | 0.027 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.391060e-01 | 0.027 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.391060e-01 | 0.027 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.391060e-01 | 0.027 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.391060e-01 | 0.027 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.391060e-01 | 0.027 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.391060e-01 | 0.027 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.391060e-01 | 0.027 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.391060e-01 | 0.027 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.399127e-01 | 0.027 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.399127e-01 | 0.027 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.410428e-01 | 0.026 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.411138e-01 | 0.026 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.417584e-01 | 0.026 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.418983e-01 | 0.026 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.451307e-01 | 0.025 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.455536e-01 | 0.024 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.459637e-01 | 0.024 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.460874e-01 | 0.024 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.460874e-01 | 0.024 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.460874e-01 | 0.024 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.460874e-01 | 0.024 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.460874e-01 | 0.024 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.466887e-01 | 0.024 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.466887e-01 | 0.024 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.501144e-01 | 0.022 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.512451e-01 | 0.022 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.512451e-01 | 0.022 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.522687e-01 | 0.021 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.522687e-01 | 0.021 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.522687e-01 | 0.021 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.522687e-01 | 0.021 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.522687e-01 | 0.021 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.522687e-01 | 0.021 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.522687e-01 | 0.021 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.522960e-01 | 0.021 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.531283e-01 | 0.021 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.547793e-01 | 0.020 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.549011e-01 | 0.020 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.549011e-01 | 0.020 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.554048e-01 | 0.020 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.554048e-01 | 0.020 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.555923e-01 | 0.020 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.577417e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.577417e-01 | 0.019 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.577417e-01 | 0.019 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.577417e-01 | 0.019 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.577417e-01 | 0.019 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.577417e-01 | 0.019 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.586225e-01 | 0.018 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.592446e-01 | 0.018 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.592446e-01 | 0.018 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.592446e-01 | 0.018 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.592464e-01 | 0.018 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.592464e-01 | 0.018 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.592464e-01 | 0.018 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.592464e-01 | 0.018 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.596743e-01 | 0.018 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.612853e-01 | 0.017 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.625873e-01 | 0.017 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.625873e-01 | 0.017 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.625873e-01 | 0.017 | 0 | 0 |
| Eicosanoids | R-HSA-211979 | 9.625873e-01 | 0.017 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.625873e-01 | 0.017 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.631886e-01 | 0.016 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.631886e-01 | 0.016 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.631886e-01 | 0.016 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.631886e-01 | 0.016 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.638769e-01 | 0.016 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.645428e-01 | 0.016 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.649551e-01 | 0.015 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.660112e-01 | 0.015 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.667628e-01 | 0.015 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.668776e-01 | 0.015 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.668776e-01 | 0.015 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.668776e-01 | 0.015 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.685930e-01 | 0.014 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.689827e-01 | 0.014 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.700016e-01 | 0.013 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.700016e-01 | 0.013 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.700016e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.700016e-01 | 0.013 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.700016e-01 | 0.013 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.703016e-01 | 0.013 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.706762e-01 | 0.013 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.706762e-01 | 0.013 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.706762e-01 | 0.013 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.706762e-01 | 0.013 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.706762e-01 | 0.013 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.706762e-01 | 0.013 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.706762e-01 | 0.013 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.706762e-01 | 0.013 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.706762e-01 | 0.013 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.734503e-01 | 0.012 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.734503e-01 | 0.012 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.740393e-01 | 0.011 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.740393e-01 | 0.011 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.740393e-01 | 0.011 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.740393e-01 | 0.011 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.740393e-01 | 0.011 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.740393e-01 | 0.011 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.742042e-01 | 0.011 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.742042e-01 | 0.011 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.743613e-01 | 0.011 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.755903e-01 | 0.011 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.770168e-01 | 0.010 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.770168e-01 | 0.010 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.770168e-01 | 0.010 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.770168e-01 | 0.010 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.770168e-01 | 0.010 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.777869e-01 | 0.010 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.779928e-01 | 0.010 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.779928e-01 | 0.010 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.779928e-01 | 0.010 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.785836e-01 | 0.009 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.789475e-01 | 0.009 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.796530e-01 | 0.009 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.796530e-01 | 0.009 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.796530e-01 | 0.009 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.796530e-01 | 0.009 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.796530e-01 | 0.009 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.801654e-01 | 0.009 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.801654e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.806915e-01 | 0.008 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.819870e-01 | 0.008 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.819870e-01 | 0.008 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.819870e-01 | 0.008 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.819870e-01 | 0.008 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.822485e-01 | 0.008 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.822485e-01 | 0.008 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.828427e-01 | 0.008 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.829011e-01 | 0.007 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.829125e-01 | 0.007 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.829125e-01 | 0.007 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.829125e-01 | 0.007 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.838480e-01 | 0.007 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.838480e-01 | 0.007 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.839039e-01 | 0.007 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.839039e-01 | 0.007 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.839039e-01 | 0.007 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.840534e-01 | 0.007 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.851189e-01 | 0.007 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.853090e-01 | 0.006 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.855066e-01 | 0.006 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.855066e-01 | 0.006 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.858828e-01 | 0.006 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.858828e-01 | 0.006 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.858828e-01 | 0.006 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.858966e-01 | 0.006 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.863926e-01 | 0.006 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.868940e-01 | 0.006 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.869536e-01 | 0.006 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.875024e-01 | 0.005 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.875024e-01 | 0.005 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.878596e-01 | 0.005 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.878596e-01 | 0.005 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.882594e-01 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.885537e-01 | 0.005 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.889363e-01 | 0.005 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.889363e-01 | 0.005 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.889363e-01 | 0.005 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.889696e-01 | 0.005 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.894344e-01 | 0.005 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.894374e-01 | 0.005 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.895252e-01 | 0.005 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.895252e-01 | 0.005 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.899814e-01 | 0.004 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.902058e-01 | 0.004 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.902058e-01 | 0.004 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.904685e-01 | 0.004 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.904998e-01 | 0.004 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.904998e-01 | 0.004 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.909035e-01 | 0.004 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.910751e-01 | 0.004 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.913297e-01 | 0.004 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.913297e-01 | 0.004 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.915518e-01 | 0.004 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.923205e-01 | 0.003 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.923246e-01 | 0.003 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.923246e-01 | 0.003 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.923246e-01 | 0.003 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.927289e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.927289e-01 | 0.003 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.930981e-01 | 0.003 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.932055e-01 | 0.003 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.932055e-01 | 0.003 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.932055e-01 | 0.003 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.932055e-01 | 0.003 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.937984e-01 | 0.003 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.937984e-01 | 0.003 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.939341e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.939853e-01 | 0.003 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.939853e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.939853e-01 | 0.003 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.944130e-01 | 0.002 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.944130e-01 | 0.002 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.944289e-01 | 0.002 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.944697e-01 | 0.002 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.946756e-01 | 0.002 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.946756e-01 | 0.002 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.949964e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.952056e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.952753e-01 | 0.002 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.952868e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.952868e-01 | 0.002 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.952868e-01 | 0.002 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.953099e-01 | 0.002 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.955071e-01 | 0.002 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.955646e-01 | 0.002 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.958278e-01 | 0.002 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.958278e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.958444e-01 | 0.002 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.959665e-01 | 0.002 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.961780e-01 | 0.002 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.962369e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.962369e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.962369e-01 | 0.002 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.963067e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.963067e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.963067e-01 | 0.002 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.963067e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.964962e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.964962e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.965932e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.966478e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.967307e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.967512e-01 | 0.001 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.971061e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.971061e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.973852e-01 | 0.001 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.974383e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.974513e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.974760e-01 | 0.001 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.978214e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.978214e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.978971e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.980107e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.980703e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.981146e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.981342e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.981342e-01 | 0.001 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.982234e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.982234e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.983099e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.984274e-01 | 0.001 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.984274e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.984853e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.985905e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.986080e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.989094e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.989105e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.989853e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.989891e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.989927e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.990242e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.990347e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.990347e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.990409e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.990869e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.992175e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.993280e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.994307e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.994387e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.994535e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.994976e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.995359e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.995892e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.996750e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.996982e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.997152e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.997156e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.997423e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.997479e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.997625e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.997769e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.997862e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.997889e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.998252e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998267e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998334e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998441e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.998453e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.998530e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.998631e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998979e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999051e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999054e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.999063e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999116e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999174e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999236e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999257e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999418e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999515e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999565e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999581e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999597e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999720e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999746e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999759e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999847e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999866e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999893e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999914e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999914e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999917e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999960e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999965e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999968e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999969e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999975e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999976e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999979e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999987e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999988e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999994e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999997e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999998e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 6.314171e-12 | 11.200 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.430922e-11 | 10.844 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.299616e-11 | 10.886 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.956873e-10 | 9.225 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.578678e-08 | 7.446 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.750708e-08 | 7.323 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.558031e-08 | 7.020 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.362110e-07 | 6.627 | 1 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.070593e-07 | 6.390 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.065147e-07 | 6.391 | 1 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.811796e-07 | 6.318 | 1 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.124360e-07 | 6.147 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.124360e-07 | 6.147 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.447257e-06 | 5.839 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.447257e-06 | 5.839 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.591891e-06 | 5.445 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.968223e-06 | 5.157 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.827111e-06 | 5.166 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.010802e-05 | 4.995 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.427707e-05 | 4.845 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.887098e-05 | 4.724 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.985409e-05 | 4.702 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.705787e-05 | 4.431 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.047290e-05 | 4.393 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.975903e-05 | 4.224 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.975903e-05 | 4.224 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.822022e-05 | 4.235 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.988480e-05 | 4.156 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.908200e-05 | 4.102 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.834017e-05 | 4.106 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.192455e-05 | 4.037 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.052586e-04 | 3.978 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.093142e-04 | 3.961 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.297118e-04 | 3.887 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.423571e-04 | 3.847 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.768474e-04 | 3.752 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.841660e-04 | 3.735 | 1 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.160549e-04 | 3.665 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.564296e-04 | 3.591 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.590211e-04 | 3.587 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.436330e-04 | 3.613 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.836207e-04 | 3.547 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.364255e-04 | 3.473 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.352045e-04 | 3.475 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.368541e-04 | 3.473 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.875089e-04 | 3.412 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.648849e-04 | 3.438 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.875089e-04 | 3.412 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.875089e-04 | 3.412 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.738395e-04 | 3.427 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.739735e-04 | 3.427 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.117083e-04 | 3.385 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.587071e-04 | 3.338 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.587071e-04 | 3.338 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.782581e-04 | 3.320 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.782581e-04 | 3.320 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.636193e-04 | 3.334 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.782581e-04 | 3.320 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.350662e-04 | 3.272 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.988111e-04 | 3.223 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.082624e-04 | 3.216 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.422937e-04 | 3.192 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.379948e-04 | 3.132 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.733082e-04 | 3.112 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.901019e-04 | 3.102 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.902689e-04 | 3.102 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.850611e-04 | 3.053 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.887160e-04 | 3.051 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 9.381381e-04 | 3.028 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.209983e-04 | 3.036 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 9.381381e-04 | 3.028 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.381381e-04 | 3.028 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 9.997998e-04 | 3.000 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.021808e-03 | 2.991 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.021808e-03 | 2.991 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.108661e-03 | 2.955 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.077858e-03 | 2.967 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.077858e-03 | 2.967 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.108661e-03 | 2.955 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.108661e-03 | 2.955 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.268240e-03 | 2.897 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.497827e-03 | 2.825 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.595955e-03 | 2.797 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.628818e-03 | 2.788 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.749776e-03 | 2.757 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.699400e-03 | 2.770 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.701309e-03 | 2.769 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.776510e-03 | 2.750 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.784132e-03 | 2.749 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.785127e-03 | 2.748 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.891355e-03 | 2.723 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.949869e-03 | 2.710 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.027954e-03 | 2.693 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.072332e-03 | 2.684 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.173611e-03 | 2.663 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.125301e-03 | 2.673 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.217753e-03 | 2.654 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.200472e-03 | 2.657 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.278633e-03 | 2.642 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.323769e-03 | 2.634 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.544601e-03 | 2.594 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.544601e-03 | 2.594 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.544601e-03 | 2.594 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.544601e-03 | 2.594 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.612749e-03 | 2.583 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.630308e-03 | 2.580 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.302897e-03 | 2.481 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 3.696698e-03 | 2.432 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.512646e-03 | 2.454 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.514568e-03 | 2.454 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.514568e-03 | 2.454 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.514568e-03 | 2.454 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.448122e-03 | 2.462 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.738105e-03 | 2.427 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.907059e-03 | 2.408 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.907059e-03 | 2.408 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.978432e-03 | 2.400 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.978432e-03 | 2.400 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.098304e-03 | 2.387 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.098304e-03 | 2.387 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.150672e-03 | 2.382 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.370528e-03 | 2.359 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.470847e-03 | 2.350 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.150672e-03 | 2.382 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.504119e-03 | 2.346 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.757579e-03 | 2.323 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.759875e-03 | 2.322 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.959604e-03 | 2.305 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.062458e-03 | 2.296 | 1 | 1 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.062458e-03 | 2.296 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.062458e-03 | 2.296 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.531219e-03 | 2.257 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.531219e-03 | 2.257 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.158730e-03 | 2.287 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.354282e-03 | 2.271 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.223401e-03 | 2.282 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.789343e-03 | 2.237 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.823534e-03 | 2.235 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.823534e-03 | 2.235 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.823534e-03 | 2.235 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.315347e-03 | 2.200 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.320993e-03 | 2.199 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.366242e-03 | 2.196 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.117851e-03 | 2.213 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.637912e-03 | 2.178 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.214237e-03 | 2.207 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.074118e-03 | 2.217 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.216469e-03 | 2.206 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.172894e-03 | 2.210 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.730735e-03 | 2.172 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.848430e-03 | 2.164 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.848430e-03 | 2.164 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.851692e-03 | 2.164 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.920391e-03 | 2.160 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.043790e-03 | 2.152 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.268715e-03 | 2.139 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 7.483635e-03 | 2.126 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.537888e-03 | 2.069 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.537888e-03 | 2.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.537888e-03 | 2.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.537888e-03 | 2.069 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.537888e-03 | 2.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.537888e-03 | 2.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.537888e-03 | 2.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.537888e-03 | 2.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.537888e-03 | 2.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.537888e-03 | 2.069 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.537888e-03 | 2.069 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 8.193625e-03 | 2.087 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 8.193625e-03 | 2.087 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.736085e-03 | 2.111 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.193625e-03 | 2.087 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.972042e-03 | 2.098 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.638711e-03 | 2.064 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.638711e-03 | 2.064 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 9.651946e-03 | 2.015 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.651946e-03 | 2.015 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 9.651946e-03 | 2.015 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.009223e-03 | 2.045 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.437878e-03 | 2.025 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.446845e-03 | 2.025 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.761227e-03 | 2.010 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.237548e-03 | 2.034 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.863362e-03 | 2.052 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.329531e-03 | 2.030 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 9.955729e-03 | 2.002 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 9.955729e-03 | 2.002 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.017454e-02 | 1.992 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.030962e-02 | 1.987 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.062932e-02 | 1.973 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.072024e-02 | 1.970 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.072024e-02 | 1.970 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.115898e-02 | 1.952 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.145036e-02 | 1.941 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.146821e-02 | 1.941 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.156732e-02 | 1.937 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.171893e-02 | 1.931 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.171893e-02 | 1.931 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.171893e-02 | 1.931 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.171893e-02 | 1.931 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.186838e-02 | 1.926 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.370008e-02 | 1.863 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.253357e-02 | 1.902 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.253357e-02 | 1.902 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.253357e-02 | 1.902 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.253357e-02 | 1.902 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.328983e-02 | 1.876 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.253357e-02 | 1.902 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.275531e-02 | 1.894 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.304605e-02 | 1.885 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.244709e-02 | 1.905 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.403344e-02 | 1.853 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.409105e-02 | 1.851 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.472791e-02 | 1.832 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.489711e-02 | 1.827 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.489711e-02 | 1.827 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.489711e-02 | 1.827 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.489711e-02 | 1.827 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.494591e-02 | 1.825 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.495632e-02 | 1.825 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.501945e-02 | 1.823 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.573341e-02 | 1.803 | 1 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.583280e-02 | 1.800 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.583280e-02 | 1.800 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.598873e-02 | 1.796 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.618021e-02 | 1.791 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.753097e-02 | 1.756 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.764527e-02 | 1.753 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.824476e-02 | 1.739 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.845476e-02 | 1.734 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.853021e-02 | 1.732 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.954266e-02 | 1.709 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.073814e-02 | 1.683 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.272630e-02 | 1.643 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.153779e-02 | 1.667 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.098013e-02 | 1.678 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.080138e-02 | 1.682 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.269205e-02 | 1.644 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.269205e-02 | 1.644 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.073814e-02 | 1.683 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.295261e-02 | 1.639 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.160884e-02 | 1.665 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.008423e-02 | 1.697 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.148608e-02 | 1.668 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.295261e-02 | 1.639 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.203348e-02 | 1.657 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.336488e-02 | 1.631 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.366026e-02 | 1.626 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.369830e-02 | 1.625 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.395862e-02 | 1.621 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.401183e-02 | 1.620 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.447869e-02 | 1.611 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.480434e-02 | 1.605 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.480745e-02 | 1.605 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.481513e-02 | 1.605 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.483636e-02 | 1.605 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.552106e-02 | 1.593 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.552106e-02 | 1.593 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.585275e-02 | 1.587 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.611476e-02 | 1.583 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.612151e-02 | 1.583 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.620255e-02 | 1.582 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.620255e-02 | 1.582 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.646181e-02 | 1.577 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.737034e-02 | 1.563 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.790382e-02 | 1.554 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.790382e-02 | 1.554 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.805963e-02 | 1.552 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.805963e-02 | 1.552 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.805963e-02 | 1.552 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.805963e-02 | 1.552 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.805963e-02 | 1.552 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.834954e-02 | 1.547 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.834954e-02 | 1.547 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.834954e-02 | 1.547 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.834954e-02 | 1.547 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.656791e-02 | 1.437 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 3.656791e-02 | 1.437 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.270206e-02 | 1.485 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.351224e-02 | 1.475 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.060384e-02 | 1.514 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.516969e-02 | 1.454 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.653674e-02 | 1.437 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.653674e-02 | 1.437 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.653674e-02 | 1.437 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.270206e-02 | 1.485 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.062255e-02 | 1.514 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.052953e-02 | 1.515 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.656791e-02 | 1.437 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.549560e-02 | 1.450 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.549560e-02 | 1.450 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.445558e-02 | 1.463 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.304136e-02 | 1.481 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.289838e-02 | 1.483 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.654576e-02 | 1.437 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.673862e-02 | 1.435 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.673862e-02 | 1.435 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.673862e-02 | 1.435 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.673862e-02 | 1.435 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.685477e-02 | 1.434 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.702831e-02 | 1.431 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.702831e-02 | 1.431 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.702831e-02 | 1.431 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.783598e-02 | 1.422 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.783598e-02 | 1.422 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.815143e-02 | 1.418 | 0 | 0 |
| Defective Base Excision Repair Associated with OGG1 | R-HSA-9656249 | 3.883256e-02 | 1.411 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.883256e-02 | 1.411 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.883256e-02 | 1.411 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.883256e-02 | 1.411 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.883256e-02 | 1.411 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.883256e-02 | 1.411 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.883256e-02 | 1.411 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.980266e-02 | 1.400 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.980266e-02 | 1.400 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.003009e-02 | 1.398 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.012346e-02 | 1.397 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.012346e-02 | 1.397 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.017480e-02 | 1.396 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.017480e-02 | 1.396 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.017480e-02 | 1.396 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.069892e-02 | 1.295 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.069892e-02 | 1.295 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.069892e-02 | 1.295 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.848748e-02 | 1.314 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.088280e-02 | 1.388 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.255438e-02 | 1.371 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.957636e-02 | 1.305 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.054283e-02 | 1.296 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.933784e-02 | 1.307 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.372919e-02 | 1.359 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.679437e-02 | 1.330 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.018342e-02 | 1.299 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 4.372919e-02 | 1.359 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.628893e-02 | 1.335 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.119637e-02 | 1.385 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.054283e-02 | 1.296 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.069892e-02 | 1.295 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.154180e-02 | 1.382 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.528033e-02 | 1.344 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.528033e-02 | 1.344 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.138224e-02 | 1.383 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.848748e-02 | 1.314 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 4.679437e-02 | 1.330 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.467899e-02 | 1.350 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.017305e-02 | 1.300 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.155468e-02 | 1.288 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.155468e-02 | 1.288 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.155468e-02 | 1.288 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.165785e-02 | 1.287 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.236513e-02 | 1.281 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.265218e-02 | 1.279 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.265218e-02 | 1.279 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 5.450107e-02 | 1.264 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.544789e-02 | 1.256 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.589201e-02 | 1.253 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.617308e-02 | 1.250 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.627601e-02 | 1.250 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.627601e-02 | 1.250 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.627601e-02 | 1.250 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.627601e-02 | 1.250 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.627601e-02 | 1.250 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.748646e-02 | 1.240 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.748646e-02 | 1.240 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.794998e-02 | 1.237 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.794998e-02 | 1.237 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.794998e-02 | 1.237 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.822753e-02 | 1.235 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.965336e-02 | 1.224 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.105551e-02 | 1.214 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.150480e-02 | 1.211 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.215588e-02 | 1.207 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.242131e-02 | 1.205 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.293075e-02 | 1.201 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.293075e-02 | 1.201 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.293075e-02 | 1.201 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.436128e-02 | 1.191 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.436128e-02 | 1.191 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.482544e-02 | 1.188 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.482544e-02 | 1.188 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.482544e-02 | 1.188 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.482544e-02 | 1.188 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.574480e-02 | 1.182 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.707687e-02 | 1.173 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.707687e-02 | 1.173 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.739041e-02 | 1.171 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.807356e-02 | 1.167 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.807356e-02 | 1.167 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.807356e-02 | 1.167 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.807356e-02 | 1.167 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.807356e-02 | 1.167 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.828265e-02 | 1.166 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 8.553786e-02 | 1.068 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.553786e-02 | 1.068 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.100972e-02 | 1.149 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.509890e-02 | 1.070 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.928552e-02 | 1.101 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.142109e-02 | 1.039 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.142109e-02 | 1.039 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.196293e-02 | 1.086 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.196293e-02 | 1.086 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.300236e-02 | 1.137 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.037198e-02 | 1.153 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.071364e-02 | 1.042 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.037198e-02 | 1.153 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.112440e-02 | 1.040 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.100972e-02 | 1.149 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.509890e-02 | 1.070 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.003261e-02 | 1.097 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.686332e-02 | 1.061 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.699415e-02 | 1.061 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.509890e-02 | 1.070 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.509890e-02 | 1.070 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.582726e-02 | 1.120 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.109596e-02 | 1.148 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.941761e-02 | 1.049 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.277100e-02 | 1.138 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.126508e-02 | 1.090 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.874847e-02 | 1.104 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 7.100972e-02 | 1.149 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.836628e-02 | 1.054 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.960367e-02 | 1.048 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.924553e-02 | 1.049 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.637304e-02 | 1.064 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.553786e-02 | 1.068 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.208575e-02 | 1.142 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.509890e-02 | 1.070 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.509890e-02 | 1.070 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.743695e-02 | 1.111 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.928552e-02 | 1.101 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.509890e-02 | 1.070 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.509890e-02 | 1.070 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.928552e-02 | 1.101 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.255376e-02 | 1.034 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 9.255376e-02 | 1.034 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 9.255376e-02 | 1.034 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.281883e-02 | 1.032 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.344335e-02 | 1.029 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.451422e-02 | 1.025 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 9.451422e-02 | 1.025 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 9.451422e-02 | 1.025 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.574979e-02 | 1.019 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.718407e-02 | 1.012 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.757308e-02 | 1.011 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.767010e-02 | 1.010 | 0 | 0 |
| Defective OGG1 Substrate Binding | R-HSA-9656255 | 9.772973e-02 | 1.010 | 0 | 0 |
| Defective OGG1 Localization | R-HSA-9657050 | 9.772973e-02 | 1.010 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 9.772973e-02 | 1.010 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.840807e-02 | 1.007 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.857420e-02 | 1.006 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.934430e-02 | 1.003 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.004357e-01 | 0.998 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.004357e-01 | 0.998 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.004357e-01 | 0.998 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.004357e-01 | 0.998 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.004357e-01 | 0.998 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.004357e-01 | 0.998 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.036012e-01 | 0.985 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.036012e-01 | 0.985 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.044528e-01 | 0.981 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.058886e-01 | 0.975 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.058886e-01 | 0.975 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.058886e-01 | 0.975 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.064811e-01 | 0.973 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.064811e-01 | 0.973 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.275159e-01 | 0.894 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.275159e-01 | 0.894 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.627178e-01 | 0.789 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 1.627178e-01 | 0.789 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.627178e-01 | 0.789 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.627178e-01 | 0.789 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.627178e-01 | 0.789 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.627178e-01 | 0.789 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.514035e-01 | 0.820 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.514035e-01 | 0.820 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.345502e-01 | 0.871 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.345502e-01 | 0.871 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.531525e-01 | 0.815 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.531525e-01 | 0.815 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.531525e-01 | 0.815 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.485436e-01 | 0.828 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.485436e-01 | 0.828 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.284492e-01 | 0.891 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.284492e-01 | 0.891 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.555792e-01 | 0.808 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.285254e-01 | 0.891 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.203828e-01 | 0.919 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.203828e-01 | 0.919 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.293039e-01 | 0.888 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.481751e-01 | 0.829 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.596935e-01 | 0.797 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.264824e-01 | 0.898 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.183459e-01 | 0.927 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.115371e-01 | 0.953 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.162503e-01 | 0.935 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.189929e-01 | 0.924 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.555792e-01 | 0.808 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.215841e-01 | 0.915 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.309479e-01 | 0.883 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.330586e-01 | 0.876 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.617062e-01 | 0.791 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.384491e-01 | 0.859 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.514035e-01 | 0.820 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.125936e-01 | 0.948 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.345502e-01 | 0.871 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.531525e-01 | 0.815 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.189929e-01 | 0.924 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.158174e-01 | 0.936 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.555792e-01 | 0.808 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.341506e-01 | 0.872 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.279174e-01 | 0.893 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.361996e-01 | 0.866 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.158174e-01 | 0.936 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.345502e-01 | 0.871 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.366484e-01 | 0.864 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.462417e-01 | 0.835 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.285254e-01 | 0.891 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 1.627178e-01 | 0.789 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.279174e-01 | 0.893 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.279174e-01 | 0.893 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.531525e-01 | 0.815 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 1.417132e-01 | 0.849 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.555792e-01 | 0.808 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.341506e-01 | 0.872 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.581091e-01 | 0.801 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.581091e-01 | 0.801 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.497149e-01 | 0.825 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.514035e-01 | 0.820 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.416988e-01 | 0.849 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.378908e-01 | 0.860 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.530627e-01 | 0.815 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.300618e-01 | 0.886 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.158174e-01 | 0.936 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.279174e-01 | 0.893 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.098601e-01 | 0.959 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.098601e-01 | 0.959 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.257590e-01 | 0.900 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.088476e-01 | 0.963 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.098601e-01 | 0.959 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.393771e-01 | 0.856 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.514035e-01 | 0.820 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.330586e-01 | 0.876 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.588286e-01 | 0.799 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.385704e-01 | 0.858 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.198059e-01 | 0.922 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.485436e-01 | 0.828 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.284492e-01 | 0.891 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.169473e-01 | 0.932 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.462417e-01 | 0.835 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.272777e-01 | 0.895 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.485436e-01 | 0.828 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.162503e-01 | 0.935 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.264824e-01 | 0.898 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.293039e-01 | 0.888 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.627178e-01 | 0.789 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.485436e-01 | 0.828 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.218328e-01 | 0.914 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.531525e-01 | 0.815 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.531525e-01 | 0.815 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.647489e-01 | 0.783 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.647489e-01 | 0.783 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.657609e-01 | 0.781 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.657609e-01 | 0.781 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.684075e-01 | 0.774 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.700137e-01 | 0.770 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.700137e-01 | 0.770 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.704619e-01 | 0.768 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.704619e-01 | 0.768 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.717844e-01 | 0.765 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.726561e-01 | 0.763 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.726561e-01 | 0.763 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.726561e-01 | 0.763 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.731101e-01 | 0.762 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.761238e-01 | 0.754 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.761238e-01 | 0.754 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.761238e-01 | 0.754 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.761238e-01 | 0.754 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.761238e-01 | 0.754 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.772801e-01 | 0.751 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.809124e-01 | 0.743 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.818381e-01 | 0.740 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.818381e-01 | 0.740 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 1.841237e-01 | 0.735 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.841237e-01 | 0.735 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.841237e-01 | 0.735 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.849802e-01 | 0.733 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.849802e-01 | 0.733 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.849802e-01 | 0.733 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.853951e-01 | 0.732 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.853951e-01 | 0.732 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.858394e-01 | 0.731 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.858798e-01 | 0.731 | 0 | 0 |
| Defective OGG1 Substrate Processing | R-HSA-9656256 | 1.859136e-01 | 0.731 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.859136e-01 | 0.731 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.859136e-01 | 0.731 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.859136e-01 | 0.731 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.859136e-01 | 0.731 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.859136e-01 | 0.731 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.859136e-01 | 0.731 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.859136e-01 | 0.731 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.859136e-01 | 0.731 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.859136e-01 | 0.731 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.859136e-01 | 0.731 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.897337e-01 | 0.722 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.897337e-01 | 0.722 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.897865e-01 | 0.722 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.929589e-01 | 0.715 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.654834e-01 | 0.576 | 0 | 0 |
| Defective GALK1 causes GALCT2 | R-HSA-5609976 | 2.654834e-01 | 0.576 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.654834e-01 | 0.576 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.654834e-01 | 0.576 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.654834e-01 | 0.576 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.654834e-01 | 0.576 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.654834e-01 | 0.576 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.993753e-01 | 0.700 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 1.993753e-01 | 0.700 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.993753e-01 | 0.700 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.993753e-01 | 0.700 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.372802e-01 | 0.472 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.372802e-01 | 0.472 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.372802e-01 | 0.472 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.372802e-01 | 0.472 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.372802e-01 | 0.472 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 3.372802e-01 | 0.472 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.372802e-01 | 0.472 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.368681e-01 | 0.625 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.368681e-01 | 0.625 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.368681e-01 | 0.625 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.018581e-01 | 0.695 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.018581e-01 | 0.695 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.746833e-01 | 0.561 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.746833e-01 | 0.561 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.746833e-01 | 0.561 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 2.746833e-01 | 0.561 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.746833e-01 | 0.561 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.746833e-01 | 0.561 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.283938e-01 | 0.641 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.283938e-01 | 0.641 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.283938e-01 | 0.641 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.283938e-01 | 0.641 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.283938e-01 | 0.641 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.283938e-01 | 0.641 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.283938e-01 | 0.641 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.283938e-01 | 0.641 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.124000e-01 | 0.505 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.124000e-01 | 0.505 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.555281e-01 | 0.593 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.555281e-01 | 0.593 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.139569e-01 | 0.670 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 2.139569e-01 | 0.670 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.990927e-01 | 0.701 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.990927e-01 | 0.701 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.990927e-01 | 0.701 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.355452e-01 | 0.628 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.496765e-01 | 0.456 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.496765e-01 | 0.456 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.496765e-01 | 0.456 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.496765e-01 | 0.456 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.576200e-01 | 0.589 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.576200e-01 | 0.589 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.576200e-01 | 0.589 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.576200e-01 | 0.589 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.108464e-01 | 0.507 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 3.108464e-01 | 0.507 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.862386e-01 | 0.413 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.862386e-01 | 0.413 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.862386e-01 | 0.413 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.862386e-01 | 0.413 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.993223e-01 | 0.700 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.545241e-01 | 0.594 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.386922e-01 | 0.470 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.386922e-01 | 0.470 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 3.386922e-01 | 0.470 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.136413e-01 | 0.670 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.493688e-01 | 0.603 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.433341e-01 | 0.614 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.257616e-01 | 0.487 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.836806e-01 | 0.547 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.961585e-01 | 0.707 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.131346e-01 | 0.504 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.433150e-01 | 0.614 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.959227e-01 | 0.708 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.795583e-01 | 0.554 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.795583e-01 | 0.554 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.940844e-01 | 0.712 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.401538e-01 | 0.620 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.060493e-01 | 0.514 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.060493e-01 | 0.514 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.942016e-01 | 0.531 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.222315e-01 | 0.492 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.385497e-01 | 0.470 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.139569e-01 | 0.670 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.459132e-01 | 0.609 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.232651e-01 | 0.651 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.576200e-01 | 0.589 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.283222e-01 | 0.641 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.131346e-01 | 0.504 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.012125e-01 | 0.521 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.060493e-01 | 0.514 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.942016e-01 | 0.531 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 2.800795e-01 | 0.553 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.732523e-01 | 0.428 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.986291e-01 | 0.525 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.986291e-01 | 0.525 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.060493e-01 | 0.514 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.496765e-01 | 0.456 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.163531e-01 | 0.665 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.663847e-01 | 0.574 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.663847e-01 | 0.574 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.068085e-01 | 0.684 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.531438e-01 | 0.452 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.682286e-01 | 0.571 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.283938e-01 | 0.641 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.496765e-01 | 0.456 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.108464e-01 | 0.507 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.330856e-01 | 0.477 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.795583e-01 | 0.554 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.956628e-01 | 0.529 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.171105e-01 | 0.663 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.576200e-01 | 0.589 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.862386e-01 | 0.413 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.789325e-01 | 0.555 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.900356e-01 | 0.538 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.900356e-01 | 0.538 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.017942e-01 | 0.695 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.098857e-01 | 0.678 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.651177e-01 | 0.577 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.848878e-01 | 0.415 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.068085e-01 | 0.684 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.116699e-01 | 0.506 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.654834e-01 | 0.576 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.124000e-01 | 0.505 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.830711e-01 | 0.548 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.496765e-01 | 0.456 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.664619e-01 | 0.436 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.728333e-01 | 0.428 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.456339e-01 | 0.461 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.487993e-01 | 0.457 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.139569e-01 | 0.670 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.816823e-01 | 0.418 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.183992e-01 | 0.497 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.954542e-01 | 0.709 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.655968e-01 | 0.576 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.693317e-01 | 0.570 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.270838e-01 | 0.485 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.993753e-01 | 0.700 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.830711e-01 | 0.548 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.108464e-01 | 0.507 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.356089e-01 | 0.628 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.857337e-01 | 0.544 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.857337e-01 | 0.544 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.248387e-01 | 0.488 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.874592e-01 | 0.541 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.624230e-01 | 0.441 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.368681e-01 | 0.625 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.163531e-01 | 0.665 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.718530e-01 | 0.430 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.368092e-01 | 0.473 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.969185e-01 | 0.527 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.995228e-01 | 0.700 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.718530e-01 | 0.430 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.139569e-01 | 0.670 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.681840e-01 | 0.572 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.709390e-01 | 0.567 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.113398e-01 | 0.507 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.849514e-01 | 0.545 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.351009e-01 | 0.629 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.569688e-01 | 0.590 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.171105e-01 | 0.663 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.139569e-01 | 0.670 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.572270e-01 | 0.447 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.686652e-01 | 0.571 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.663847e-01 | 0.574 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.526196e-01 | 0.598 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.473180e-01 | 0.607 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.654834e-01 | 0.576 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.654834e-01 | 0.576 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 1.993753e-01 | 0.700 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.993753e-01 | 0.700 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.372802e-01 | 0.472 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.372802e-01 | 0.472 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.372802e-01 | 0.472 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.018581e-01 | 0.695 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 2.139569e-01 | 0.670 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.171105e-01 | 0.663 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.862386e-01 | 0.413 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.862386e-01 | 0.413 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.742234e-01 | 0.562 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.832275e-01 | 0.548 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.547886e-01 | 0.450 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.323292e-01 | 0.478 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.720332e-01 | 0.429 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.549717e-01 | 0.450 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.136413e-01 | 0.670 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.113398e-01 | 0.507 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.968312e-01 | 0.706 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.060493e-01 | 0.514 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.060493e-01 | 0.514 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.732523e-01 | 0.428 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.503491e-01 | 0.601 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.996150e-01 | 0.523 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.496765e-01 | 0.456 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.163531e-01 | 0.665 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.843900e-01 | 0.415 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.487993e-01 | 0.457 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.116699e-01 | 0.506 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.098857e-01 | 0.678 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.787532e-01 | 0.555 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.368681e-01 | 0.625 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.746833e-01 | 0.561 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.746833e-01 | 0.561 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.496765e-01 | 0.456 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.576200e-01 | 0.589 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.900356e-01 | 0.538 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.697163e-01 | 0.569 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.805894e-01 | 0.420 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.742234e-01 | 0.562 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.390630e-01 | 0.470 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.412883e-01 | 0.467 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.386922e-01 | 0.470 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.060493e-01 | 0.514 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.355452e-01 | 0.628 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.663847e-01 | 0.574 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.515882e-01 | 0.599 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.737922e-01 | 0.563 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.933498e-01 | 0.533 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.986291e-01 | 0.525 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.993753e-01 | 0.700 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.372802e-01 | 0.472 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 2.746833e-01 | 0.561 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 2.830711e-01 | 0.548 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.108464e-01 | 0.507 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.545241e-01 | 0.594 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.732523e-01 | 0.428 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.732523e-01 | 0.428 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.732523e-01 | 0.428 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.547886e-01 | 0.450 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.714659e-01 | 0.430 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.028249e-01 | 0.519 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.283222e-01 | 0.641 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.232651e-01 | 0.651 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.496765e-01 | 0.456 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.862386e-01 | 0.413 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.131346e-01 | 0.504 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.969185e-01 | 0.527 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.986097e-01 | 0.525 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.545241e-01 | 0.594 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.143696e-01 | 0.503 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.487993e-01 | 0.457 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 1.993753e-01 | 0.700 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.131346e-01 | 0.504 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.671036e-01 | 0.573 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.993753e-01 | 0.700 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.746833e-01 | 0.561 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.746833e-01 | 0.561 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.830711e-01 | 0.548 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.496765e-01 | 0.456 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.496765e-01 | 0.456 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.108464e-01 | 0.507 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.862386e-01 | 0.413 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.993199e-01 | 0.524 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.386922e-01 | 0.470 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.257616e-01 | 0.487 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.496765e-01 | 0.456 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.496765e-01 | 0.456 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.800795e-01 | 0.553 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.496765e-01 | 0.456 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.862386e-01 | 0.413 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.742234e-01 | 0.562 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.268443e-01 | 0.486 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.800795e-01 | 0.553 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.546016e-01 | 0.450 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.028249e-01 | 0.519 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.880761e-01 | 0.411 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.899878e-01 | 0.409 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.909033e-01 | 0.408 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.909033e-01 | 0.408 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.909033e-01 | 0.408 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.909033e-01 | 0.408 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.933567e-01 | 0.405 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.933567e-01 | 0.405 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.933567e-01 | 0.405 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.948432e-01 | 0.404 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 3.948432e-01 | 0.404 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 3.948432e-01 | 0.404 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 3.948432e-01 | 0.404 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.948432e-01 | 0.404 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.948432e-01 | 0.404 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.948432e-01 | 0.404 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.960538e-01 | 0.402 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.011264e-01 | 0.397 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.016712e-01 | 0.396 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.020629e-01 | 0.396 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.020629e-01 | 0.396 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.020629e-01 | 0.396 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.020629e-01 | 0.396 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.020629e-01 | 0.396 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.020629e-01 | 0.396 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.020629e-01 | 0.396 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.089601e-01 | 0.388 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.134054e-01 | 0.384 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.134054e-01 | 0.384 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.134054e-01 | 0.384 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.134054e-01 | 0.384 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.155911e-01 | 0.381 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.155911e-01 | 0.381 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.176959e-01 | 0.379 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.176959e-01 | 0.379 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.176959e-01 | 0.379 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.176959e-01 | 0.379 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.210770e-01 | 0.376 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.212613e-01 | 0.375 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.218700e-01 | 0.375 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.218700e-01 | 0.375 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 4.218700e-01 | 0.375 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.269668e-01 | 0.370 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.277124e-01 | 0.369 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.277124e-01 | 0.369 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.309236e-01 | 0.366 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.309236e-01 | 0.366 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.333499e-01 | 0.363 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.333499e-01 | 0.363 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.375600e-01 | 0.359 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.403433e-01 | 0.356 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.403433e-01 | 0.356 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.403433e-01 | 0.356 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.428577e-01 | 0.354 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.448883e-01 | 0.352 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.457918e-01 | 0.351 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.462135e-01 | 0.350 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.480714e-01 | 0.349 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 4.480714e-01 | 0.349 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.480714e-01 | 0.349 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.480714e-01 | 0.349 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.480714e-01 | 0.349 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.531444e-01 | 0.344 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.531444e-01 | 0.344 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.531444e-01 | 0.344 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.531444e-01 | 0.344 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.539702e-01 | 0.343 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.539702e-01 | 0.343 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.564034e-01 | 0.341 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.564034e-01 | 0.341 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.564034e-01 | 0.341 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.564034e-01 | 0.341 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.564034e-01 | 0.341 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.564034e-01 | 0.341 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.564034e-01 | 0.341 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.587884e-01 | 0.338 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.605164e-01 | 0.337 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.605164e-01 | 0.337 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.605164e-01 | 0.337 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.605164e-01 | 0.337 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.605164e-01 | 0.337 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.605164e-01 | 0.337 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.605164e-01 | 0.337 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.605164e-01 | 0.337 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 4.605164e-01 | 0.337 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.605164e-01 | 0.337 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.605164e-01 | 0.337 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.614393e-01 | 0.336 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.626912e-01 | 0.335 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.626912e-01 | 0.335 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.626912e-01 | 0.335 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.627233e-01 | 0.335 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.627233e-01 | 0.335 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.627233e-01 | 0.335 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.677774e-01 | 0.330 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.727464e-01 | 0.325 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 4.727464e-01 | 0.325 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.727464e-01 | 0.325 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.732830e-01 | 0.325 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.743653e-01 | 0.324 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.743653e-01 | 0.324 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 4.743653e-01 | 0.324 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.743653e-01 | 0.324 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.747989e-01 | 0.323 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.803442e-01 | 0.318 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.803442e-01 | 0.318 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.819683e-01 | 0.317 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 4.819683e-01 | 0.317 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.825222e-01 | 0.316 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.847799e-01 | 0.314 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 4.847799e-01 | 0.314 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.847799e-01 | 0.314 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.864707e-01 | 0.313 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.864707e-01 | 0.313 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.864707e-01 | 0.313 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.864887e-01 | 0.313 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.864887e-01 | 0.313 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.897130e-01 | 0.310 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.897130e-01 | 0.310 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.897130e-01 | 0.310 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.897130e-01 | 0.310 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.897130e-01 | 0.310 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.897130e-01 | 0.310 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.916078e-01 | 0.308 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 4.924442e-01 | 0.308 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.960683e-01 | 0.304 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.000010e-01 | 0.301 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.000670e-01 | 0.301 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 5.000670e-01 | 0.301 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.000670e-01 | 0.301 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.064630e-01 | 0.295 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.064630e-01 | 0.295 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.064630e-01 | 0.295 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.064630e-01 | 0.295 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.112195e-01 | 0.291 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.112195e-01 | 0.291 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.112195e-01 | 0.291 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.132586e-01 | 0.290 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.132586e-01 | 0.290 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.132586e-01 | 0.290 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.132586e-01 | 0.290 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.132586e-01 | 0.290 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 5.132586e-01 | 0.290 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.132586e-01 | 0.290 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.132586e-01 | 0.290 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.132586e-01 | 0.290 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.132586e-01 | 0.290 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.183887e-01 | 0.285 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.212108e-01 | 0.283 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.217082e-01 | 0.283 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.217082e-01 | 0.283 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.217082e-01 | 0.283 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.217082e-01 | 0.283 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.251123e-01 | 0.280 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.251123e-01 | 0.280 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.277279e-01 | 0.278 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.277327e-01 | 0.278 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.321198e-01 | 0.274 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.321198e-01 | 0.274 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.321198e-01 | 0.274 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.340759e-01 | 0.272 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.340759e-01 | 0.272 | 0 | 0 |
| Translation | R-HSA-72766 | 5.368839e-01 | 0.270 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.375174e-01 | 0.270 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.393439e-01 | 0.268 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.484938e-01 | 0.261 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.484938e-01 | 0.261 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.484938e-01 | 0.261 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.484938e-01 | 0.261 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.485357e-01 | 0.261 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 5.485357e-01 | 0.261 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.485357e-01 | 0.261 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.485357e-01 | 0.261 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.485357e-01 | 0.261 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.494483e-01 | 0.260 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.494483e-01 | 0.260 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.522137e-01 | 0.258 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.523276e-01 | 0.258 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.523276e-01 | 0.258 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.523276e-01 | 0.258 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.523276e-01 | 0.258 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.523276e-01 | 0.258 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.523276e-01 | 0.258 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.523276e-01 | 0.258 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.593108e-01 | 0.252 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.608474e-01 | 0.251 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.608474e-01 | 0.251 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.608474e-01 | 0.251 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.608474e-01 | 0.251 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.608474e-01 | 0.251 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.608474e-01 | 0.251 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.608474e-01 | 0.251 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.608474e-01 | 0.251 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.608474e-01 | 0.251 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.608474e-01 | 0.251 | 0 | 0 |
| Threonine catabolism | R-HSA-8849175 | 5.608474e-01 | 0.251 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.608474e-01 | 0.251 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.608474e-01 | 0.251 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.608474e-01 | 0.251 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 5.608474e-01 | 0.251 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.608474e-01 | 0.251 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.632863e-01 | 0.249 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.646170e-01 | 0.248 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.648123e-01 | 0.248 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.653313e-01 | 0.248 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.654023e-01 | 0.248 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.658175e-01 | 0.247 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.658175e-01 | 0.247 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.663764e-01 | 0.247 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.666093e-01 | 0.247 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.666093e-01 | 0.247 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.676455e-01 | 0.246 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.688526e-01 | 0.245 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.688526e-01 | 0.245 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.688526e-01 | 0.245 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.730326e-01 | 0.242 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.786982e-01 | 0.238 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.796502e-01 | 0.237 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.815344e-01 | 0.235 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.815344e-01 | 0.235 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.815344e-01 | 0.235 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.815344e-01 | 0.235 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 5.815344e-01 | 0.235 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 5.843449e-01 | 0.233 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 5.843449e-01 | 0.233 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.885859e-01 | 0.230 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.886501e-01 | 0.230 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.914444e-01 | 0.228 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.958318e-01 | 0.225 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.958318e-01 | 0.225 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.975033e-01 | 0.224 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.985767e-01 | 0.223 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.021856e-01 | 0.220 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.037859e-01 | 0.219 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.037859e-01 | 0.219 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.037859e-01 | 0.219 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 6.037859e-01 | 0.219 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.037859e-01 | 0.219 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.037859e-01 | 0.219 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.037859e-01 | 0.219 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.037859e-01 | 0.219 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.037859e-01 | 0.219 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.037859e-01 | 0.219 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.037859e-01 | 0.219 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.061226e-01 | 0.217 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.065868e-01 | 0.217 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.079041e-01 | 0.216 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.079041e-01 | 0.216 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.079041e-01 | 0.216 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.079041e-01 | 0.216 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.090562e-01 | 0.215 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.093121e-01 | 0.215 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.093121e-01 | 0.215 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.093121e-01 | 0.215 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.093121e-01 | 0.215 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.093121e-01 | 0.215 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.178214e-01 | 0.209 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.256190e-01 | 0.204 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.282924e-01 | 0.202 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.326318e-01 | 0.199 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.356609e-01 | 0.197 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.356609e-01 | 0.197 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.356609e-01 | 0.197 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.356609e-01 | 0.197 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.356609e-01 | 0.197 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.389844e-01 | 0.195 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.389844e-01 | 0.195 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.425284e-01 | 0.192 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.425284e-01 | 0.192 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.425284e-01 | 0.192 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.425284e-01 | 0.192 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.425284e-01 | 0.192 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.425284e-01 | 0.192 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.425284e-01 | 0.192 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.425284e-01 | 0.192 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.425284e-01 | 0.192 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.425284e-01 | 0.192 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.425284e-01 | 0.192 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.425284e-01 | 0.192 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.425284e-01 | 0.192 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.425284e-01 | 0.192 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.425284e-01 | 0.192 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.425284e-01 | 0.192 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.425284e-01 | 0.192 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.447083e-01 | 0.191 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 6.447083e-01 | 0.191 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.447083e-01 | 0.191 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.451513e-01 | 0.190 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.460453e-01 | 0.190 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.460453e-01 | 0.190 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.480962e-01 | 0.188 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.581254e-01 | 0.182 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.593107e-01 | 0.181 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.593107e-01 | 0.181 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.593107e-01 | 0.181 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.593107e-01 | 0.181 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.605946e-01 | 0.180 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.605946e-01 | 0.180 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.605946e-01 | 0.180 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 6.605946e-01 | 0.180 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.606116e-01 | 0.180 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 6.610428e-01 | 0.180 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.774846e-01 | 0.169 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.774846e-01 | 0.169 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.774846e-01 | 0.169 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.774846e-01 | 0.169 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 6.774846e-01 | 0.169 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.774846e-01 | 0.169 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.774846e-01 | 0.169 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.774846e-01 | 0.169 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.774846e-01 | 0.169 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.774846e-01 | 0.169 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.774846e-01 | 0.169 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.774846e-01 | 0.169 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.774846e-01 | 0.169 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.774846e-01 | 0.169 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.774846e-01 | 0.169 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.774846e-01 | 0.169 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.787963e-01 | 0.168 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.787963e-01 | 0.168 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.787963e-01 | 0.168 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.787963e-01 | 0.168 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.787963e-01 | 0.168 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.791582e-01 | 0.168 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 6.791582e-01 | 0.168 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.791582e-01 | 0.168 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.791582e-01 | 0.168 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.825470e-01 | 0.166 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.825522e-01 | 0.166 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.825522e-01 | 0.166 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.825522e-01 | 0.166 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.841381e-01 | 0.165 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.841381e-01 | 0.165 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.841381e-01 | 0.165 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.841381e-01 | 0.165 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.841381e-01 | 0.165 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.841381e-01 | 0.165 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.841381e-01 | 0.165 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.879130e-01 | 0.162 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.882982e-01 | 0.162 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.898242e-01 | 0.161 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.938553e-01 | 0.159 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.943421e-01 | 0.158 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.954827e-01 | 0.158 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.964765e-01 | 0.157 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.974425e-01 | 0.156 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.974425e-01 | 0.156 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.974425e-01 | 0.156 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.978649e-01 | 0.156 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.983725e-01 | 0.156 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.989343e-01 | 0.156 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.989679e-01 | 0.156 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.036184e-01 | 0.153 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.063247e-01 | 0.151 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.063247e-01 | 0.151 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.063247e-01 | 0.151 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.063247e-01 | 0.151 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.063247e-01 | 0.151 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.090244e-01 | 0.149 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.090244e-01 | 0.149 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.090244e-01 | 0.149 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.090244e-01 | 0.149 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.090244e-01 | 0.149 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.090244e-01 | 0.149 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.090244e-01 | 0.149 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.090244e-01 | 0.149 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.090244e-01 | 0.149 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.112040e-01 | 0.148 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.112040e-01 | 0.148 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.112040e-01 | 0.148 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.112040e-01 | 0.148 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.112040e-01 | 0.148 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.112040e-01 | 0.148 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.112040e-01 | 0.148 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.112040e-01 | 0.148 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.119207e-01 | 0.148 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.152555e-01 | 0.146 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.152555e-01 | 0.146 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.170813e-01 | 0.144 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.224159e-01 | 0.141 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.237905e-01 | 0.140 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.243656e-01 | 0.140 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.243656e-01 | 0.140 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.245178e-01 | 0.140 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.245178e-01 | 0.140 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.263231e-01 | 0.139 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.271947e-01 | 0.138 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.271947e-01 | 0.138 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.271947e-01 | 0.138 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.317029e-01 | 0.136 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.322453e-01 | 0.135 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.322453e-01 | 0.135 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 7.322453e-01 | 0.135 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.347485e-01 | 0.134 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.374815e-01 | 0.132 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.374815e-01 | 0.132 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 7.374815e-01 | 0.132 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.374815e-01 | 0.132 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.374815e-01 | 0.132 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.374815e-01 | 0.132 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.374815e-01 | 0.132 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.374815e-01 | 0.132 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 7.374815e-01 | 0.132 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.374815e-01 | 0.132 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.383943e-01 | 0.132 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.383943e-01 | 0.132 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.383943e-01 | 0.132 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.408438e-01 | 0.130 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.467932e-01 | 0.127 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.482824e-01 | 0.126 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.484255e-01 | 0.126 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.485410e-01 | 0.126 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.485410e-01 | 0.126 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.547718e-01 | 0.122 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.547718e-01 | 0.122 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.590949e-01 | 0.120 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.599685e-01 | 0.119 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.626615e-01 | 0.118 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.631570e-01 | 0.117 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.631570e-01 | 0.117 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.631570e-01 | 0.117 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.631570e-01 | 0.117 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.631570e-01 | 0.117 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.631570e-01 | 0.117 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.631570e-01 | 0.117 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.631570e-01 | 0.117 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.631570e-01 | 0.117 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.631570e-01 | 0.117 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.631570e-01 | 0.117 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.631570e-01 | 0.117 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.638128e-01 | 0.117 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.651694e-01 | 0.116 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.681149e-01 | 0.115 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.681149e-01 | 0.115 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.692281e-01 | 0.114 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.744946e-01 | 0.111 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.784261e-01 | 0.109 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 7.784261e-01 | 0.109 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.793738e-01 | 0.108 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.823748e-01 | 0.107 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 7.823748e-01 | 0.107 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.823748e-01 | 0.107 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.823748e-01 | 0.107 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.858703e-01 | 0.105 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.858703e-01 | 0.105 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.863228e-01 | 0.104 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 7.863228e-01 | 0.104 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.863228e-01 | 0.104 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.863228e-01 | 0.104 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.863228e-01 | 0.104 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.863228e-01 | 0.104 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.863228e-01 | 0.104 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.870944e-01 | 0.104 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.876869e-01 | 0.104 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.876869e-01 | 0.104 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.954820e-01 | 0.099 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.964752e-01 | 0.099 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.967952e-01 | 0.099 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.984625e-01 | 0.098 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.984625e-01 | 0.098 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.051349e-01 | 0.094 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.063253e-01 | 0.093 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 8.072239e-01 | 0.093 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.072239e-01 | 0.093 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.072239e-01 | 0.093 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.072239e-01 | 0.093 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.072239e-01 | 0.093 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.072239e-01 | 0.093 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.072239e-01 | 0.093 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.072239e-01 | 0.093 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.072239e-01 | 0.093 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.072239e-01 | 0.093 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.072239e-01 | 0.093 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.072239e-01 | 0.093 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.072239e-01 | 0.093 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.072239e-01 | 0.093 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.105126e-01 | 0.091 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.107522e-01 | 0.091 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.113792e-01 | 0.091 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.134866e-01 | 0.090 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.134866e-01 | 0.090 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.134866e-01 | 0.090 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.173243e-01 | 0.088 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.175615e-01 | 0.087 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.178406e-01 | 0.087 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.178406e-01 | 0.087 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.205490e-01 | 0.086 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.205490e-01 | 0.086 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.241066e-01 | 0.084 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 8.260816e-01 | 0.083 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 8.260816e-01 | 0.083 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.260816e-01 | 0.083 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.260816e-01 | 0.083 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.260816e-01 | 0.083 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.260816e-01 | 0.083 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.260816e-01 | 0.083 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.260816e-01 | 0.083 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.260816e-01 | 0.083 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.260816e-01 | 0.083 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.260816e-01 | 0.083 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.260816e-01 | 0.083 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.269464e-01 | 0.083 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.275012e-01 | 0.082 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.275012e-01 | 0.082 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.295831e-01 | 0.081 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.304988e-01 | 0.081 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.364365e-01 | 0.078 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.378256e-01 | 0.077 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.383941e-01 | 0.077 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.405599e-01 | 0.075 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.405599e-01 | 0.075 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.405599e-01 | 0.075 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.405599e-01 | 0.075 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.430957e-01 | 0.074 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.430957e-01 | 0.074 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.430957e-01 | 0.074 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 8.430957e-01 | 0.074 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.430957e-01 | 0.074 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.430957e-01 | 0.074 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.430957e-01 | 0.074 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.430957e-01 | 0.074 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.440149e-01 | 0.074 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.449546e-01 | 0.073 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.460948e-01 | 0.073 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.460948e-01 | 0.073 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.511267e-01 | 0.070 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.527155e-01 | 0.069 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.527155e-01 | 0.069 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.527155e-01 | 0.069 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.527155e-01 | 0.069 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.527155e-01 | 0.069 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.527155e-01 | 0.069 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.527155e-01 | 0.069 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.527155e-01 | 0.069 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.533619e-01 | 0.069 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.533619e-01 | 0.069 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.545639e-01 | 0.068 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.584462e-01 | 0.066 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.584462e-01 | 0.066 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.584462e-01 | 0.066 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.584462e-01 | 0.066 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.584462e-01 | 0.066 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.584462e-01 | 0.066 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.584462e-01 | 0.066 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.584462e-01 | 0.066 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 8.584462e-01 | 0.066 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.591199e-01 | 0.066 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.609800e-01 | 0.065 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.613862e-01 | 0.065 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.638404e-01 | 0.064 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.683401e-01 | 0.061 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.702558e-01 | 0.060 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.718747e-01 | 0.060 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.722957e-01 | 0.059 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.722957e-01 | 0.059 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.722957e-01 | 0.059 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.722957e-01 | 0.059 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.722957e-01 | 0.059 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.722957e-01 | 0.059 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.722957e-01 | 0.059 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 8.722957e-01 | 0.059 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.722957e-01 | 0.059 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.722957e-01 | 0.059 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.745230e-01 | 0.058 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.745230e-01 | 0.058 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.745230e-01 | 0.058 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.751753e-01 | 0.058 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.754551e-01 | 0.058 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.754551e-01 | 0.058 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.789802e-01 | 0.056 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.817107e-01 | 0.055 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.842735e-01 | 0.053 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.842735e-01 | 0.053 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 8.847910e-01 | 0.053 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.847910e-01 | 0.053 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.847910e-01 | 0.053 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.847910e-01 | 0.053 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.847910e-01 | 0.053 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 8.847910e-01 | 0.053 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.847910e-01 | 0.053 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.847910e-01 | 0.053 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.847910e-01 | 0.053 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.847910e-01 | 0.053 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.847910e-01 | 0.053 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.898830e-01 | 0.051 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.909385e-01 | 0.050 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.909385e-01 | 0.050 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.933953e-01 | 0.049 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.943243e-01 | 0.049 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.957334e-01 | 0.048 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.957334e-01 | 0.048 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.960643e-01 | 0.048 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.960643e-01 | 0.048 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.960643e-01 | 0.048 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.960643e-01 | 0.048 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 8.960643e-01 | 0.048 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.960643e-01 | 0.048 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 8.960643e-01 | 0.048 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.960643e-01 | 0.048 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.960643e-01 | 0.048 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.960643e-01 | 0.048 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.960643e-01 | 0.048 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.960643e-01 | 0.048 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.000466e-01 | 0.046 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.050326e-01 | 0.043 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.062351e-01 | 0.043 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.062351e-01 | 0.043 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.062351e-01 | 0.043 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.062351e-01 | 0.043 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.062351e-01 | 0.043 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.069073e-01 | 0.042 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.086741e-01 | 0.042 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.094099e-01 | 0.041 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.094663e-01 | 0.041 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.094663e-01 | 0.041 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.094663e-01 | 0.041 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.127744e-01 | 0.040 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.152160e-01 | 0.038 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.152160e-01 | 0.038 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.152160e-01 | 0.038 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.152953e-01 | 0.038 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.154111e-01 | 0.038 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.154111e-01 | 0.038 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.154111e-01 | 0.038 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.154111e-01 | 0.038 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.154111e-01 | 0.038 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.154111e-01 | 0.038 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.154111e-01 | 0.038 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.154111e-01 | 0.038 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.166534e-01 | 0.038 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.211550e-01 | 0.036 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.215575e-01 | 0.035 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.229724e-01 | 0.035 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.233015e-01 | 0.035 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.233015e-01 | 0.035 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.233015e-01 | 0.035 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.236897e-01 | 0.034 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.236897e-01 | 0.034 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.236897e-01 | 0.034 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.236897e-01 | 0.034 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.236897e-01 | 0.034 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.236897e-01 | 0.034 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.236897e-01 | 0.034 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.294472e-01 | 0.032 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.294472e-01 | 0.032 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.294472e-01 | 0.032 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.294472e-01 | 0.032 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.311585e-01 | 0.031 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.311585e-01 | 0.031 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.311585e-01 | 0.031 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.311585e-01 | 0.031 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.311585e-01 | 0.031 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.311585e-01 | 0.031 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.311585e-01 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.311585e-01 | 0.031 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.311585e-01 | 0.031 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.351252e-01 | 0.029 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.359060e-01 | 0.029 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.378967e-01 | 0.028 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.378967e-01 | 0.028 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.378967e-01 | 0.028 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.378967e-01 | 0.028 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.378967e-01 | 0.028 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.378967e-01 | 0.028 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.378967e-01 | 0.028 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.400081e-01 | 0.027 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.403680e-01 | 0.027 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.403680e-01 | 0.027 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.411193e-01 | 0.026 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.431383e-01 | 0.025 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.433662e-01 | 0.025 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.439757e-01 | 0.025 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 9.439757e-01 | 0.025 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.439757e-01 | 0.025 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.439757e-01 | 0.025 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.439757e-01 | 0.025 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.439757e-01 | 0.025 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.439757e-01 | 0.025 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.439757e-01 | 0.025 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.439757e-01 | 0.025 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.439757e-01 | 0.025 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.452065e-01 | 0.024 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.452065e-01 | 0.024 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.455206e-01 | 0.024 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.494600e-01 | 0.023 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.494600e-01 | 0.023 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.494600e-01 | 0.023 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.494600e-01 | 0.023 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.494600e-01 | 0.023 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.494600e-01 | 0.023 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.494600e-01 | 0.023 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.494600e-01 | 0.023 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.494600e-01 | 0.023 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.494600e-01 | 0.023 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.494600e-01 | 0.023 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.496695e-01 | 0.022 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.498223e-01 | 0.022 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.498223e-01 | 0.022 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.504119e-01 | 0.022 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.509728e-01 | 0.022 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.527574e-01 | 0.021 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.537842e-01 | 0.021 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.537842e-01 | 0.021 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.544077e-01 | 0.020 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.544077e-01 | 0.020 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.544077e-01 | 0.020 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.544077e-01 | 0.020 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.544077e-01 | 0.020 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.544077e-01 | 0.020 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.544077e-01 | 0.020 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.588713e-01 | 0.018 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.588713e-01 | 0.018 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.588713e-01 | 0.018 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.588713e-01 | 0.018 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.610685e-01 | 0.017 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.610685e-01 | 0.017 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.610685e-01 | 0.017 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.610685e-01 | 0.017 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.628982e-01 | 0.016 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.628982e-01 | 0.016 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.628982e-01 | 0.016 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.628982e-01 | 0.016 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.639986e-01 | 0.016 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.642841e-01 | 0.016 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.664441e-01 | 0.015 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.665310e-01 | 0.015 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.665310e-01 | 0.015 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.665310e-01 | 0.015 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.672436e-01 | 0.014 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.673327e-01 | 0.014 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.680565e-01 | 0.014 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.698083e-01 | 0.013 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.698083e-01 | 0.013 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.698083e-01 | 0.013 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.698083e-01 | 0.013 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.698083e-01 | 0.013 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.698083e-01 | 0.013 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.698083e-01 | 0.013 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.699661e-01 | 0.013 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.699661e-01 | 0.013 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.724698e-01 | 0.012 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.724698e-01 | 0.012 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.726603e-01 | 0.012 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.727648e-01 | 0.012 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.727648e-01 | 0.012 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.743122e-01 | 0.011 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.743905e-01 | 0.011 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.747191e-01 | 0.011 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.747713e-01 | 0.011 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.754214e-01 | 0.011 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.754320e-01 | 0.011 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.754320e-01 | 0.011 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.763712e-01 | 0.010 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.763712e-01 | 0.010 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.765077e-01 | 0.010 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.768863e-01 | 0.010 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.778382e-01 | 0.010 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.782490e-01 | 0.010 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.786164e-01 | 0.009 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.800088e-01 | 0.009 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.800088e-01 | 0.009 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.819669e-01 | 0.008 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.837333e-01 | 0.007 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.837333e-01 | 0.007 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.837544e-01 | 0.007 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.837544e-01 | 0.007 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.850272e-01 | 0.007 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.851335e-01 | 0.007 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.853268e-01 | 0.006 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.853268e-01 | 0.006 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.853268e-01 | 0.006 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.853268e-01 | 0.006 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.853268e-01 | 0.006 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.858300e-01 | 0.006 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.861707e-01 | 0.006 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.863984e-01 | 0.006 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.863984e-01 | 0.006 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.866272e-01 | 0.006 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.867643e-01 | 0.006 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.867643e-01 | 0.006 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.872397e-01 | 0.006 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.876342e-01 | 0.005 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.880610e-01 | 0.005 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.886215e-01 | 0.005 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.892308e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.892308e-01 | 0.005 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.892308e-01 | 0.005 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.892308e-01 | 0.005 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.892308e-01 | 0.005 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.900245e-01 | 0.004 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.912379e-01 | 0.004 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.912379e-01 | 0.004 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.922749e-01 | 0.003 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.927411e-01 | 0.003 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.927411e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.927411e-01 | 0.003 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.928711e-01 | 0.003 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.928711e-01 | 0.003 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.930420e-01 | 0.003 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.935698e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.939345e-01 | 0.003 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.947685e-01 | 0.002 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.947685e-01 | 0.002 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.949494e-01 | 0.002 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.951243e-01 | 0.002 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.951954e-01 | 0.002 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.952813e-01 | 0.002 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.952813e-01 | 0.002 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.952813e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.957439e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.961587e-01 | 0.002 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.961587e-01 | 0.002 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.965375e-01 | 0.002 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.968770e-01 | 0.001 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.970822e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.971832e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.971832e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.973134e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.973385e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.973385e-01 | 0.001 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.973385e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.974594e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.974594e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.976811e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.977086e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.977865e-01 | 0.001 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.977945e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.985425e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.986067e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.986325e-01 | 0.001 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.987166e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.987304e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.987666e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.987666e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.989636e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.989968e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.989968e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.990921e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.990952e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.991762e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.991840e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.991840e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.993363e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.994014e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.995017e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.995131e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.995609e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.995609e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996040e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.996040e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.996402e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.996724e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.996897e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997096e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997096e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997096e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.997170e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997381e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.997597e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.997870e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.997964e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998313e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998575e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.998591e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.998642e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998709e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998730e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998967e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998967e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999243e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999321e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999357e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999366e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999445e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999451e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999533e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999661e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999697e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999781e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999803e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999915e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999924e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999935e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999947e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999957e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999959e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999959e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999969e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999989e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999990e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999991e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999993e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999994e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999994e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999996e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999997e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |